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A Promise Realized? A Critical Review of 
Accountable Care Organizations Since 
the Enactment of the Affordable Care Act 
JEAN PHILLIP SHAMI* 
As the six-year anniversary of the passage of the Afford-
able Care Act (“ACA”) comes to a close, a critical review 
of one of the key inventions of the ACA—Accountable Care 
Organizations (“ACOs”)—is timely as part of the greater 
narrative around affordable, quality health care in America. 
This Comment begins with a discussion of the statutory cre-
ation, philosophy and vision, and organizational structure of 
ACOs in the context of the passage of the ACA in 2010. Then, 
it will critically review ACOs from three perspectives based 
on the ACO model’s mission to provide better care for more 
people at a lower cost. The first critical perspective will ad-
dress the concept of “bending the cost curve” to understand 
whether ACOs have effectively reduced costs, both statuto-
rily and practically. The second critical perspective will con-
sider the “quality of care” framework used to “grade” 
ACOs, questioning whether this grading system is effec-
tive—or even sufficient—to improve the quality of health 
care. The third critical perspective will evaluate whether 
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ACOs have enabled greater access to care for all Ameri-
cans—an aspiration for a renewed American health care 
system—or simply intensified the marginalization of access 
to health care in this country. It is undeniable that the ACO 
model of care could greatly impact health outcomes in the 
United States by restructuring the delivery system of patient 
care. 
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Perhaps the most meaningful contribution of the 
ACO model is that it gives providers a reason to 
change the culture of medicine. It asks providers 
across specialties to work together and coordinate 
care in a way that was not rewarded under fee-for-
service. It asks organizations to stitch the separate 
pieces of the patient’s care trajectory together 
through teamwork. In the long run, this may be the 
most intangible but substantive legacy that the ACO 
model provides. Under a single, collective contract at 
the organizational level, providers are quite literally 
in it together. If providers can break down silos, [of-
fer] better care coordination, and manage population 
health with a collective vision towards keeping pa-
tients healthy, the ACO paradigm would be able to 
claim a profound achievement. Such changes, how-
ever, will take time and they are not guaranteed.1 
On March 23, 2010, as President Obama signed into law the Pa-
tient Protection and Affordable Care Act (“ACA”),2 politicians and 
the public reacted both positively and negatively. Proponents re-
joiced as they believed the ACA was a step forward towards univer-
sal health care coverage in the United States.3 Opponents, however, 
                                                                                                             
 1 Zirui Song, Accountable Care Organizations: Early Results and Future 
Challenges, 21 J. CLINICAL OUTCOMES MGMT. 364, 364–71 (Aug. 2014). 
 2 Patient Protection and Affordable Care Act (PPACA) of 2010, Pub. L. No. 
111-148, 124 Stat. 119 (codified as amended in scattered sections of 42 U.S.C.). 
 3 Donald M. Berwick, Launching Accountable Care Organizations—The 
Proposed Rule for the Medicare Shared Savings Program, NEW ENG. J. MED. 1, 
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maintained a high cry that the ACA violated individual liberties, 
portraying the ACA as the manifestation of “a larger and larger gov-
ernment, more and more intrusive in your life . . . that potentially 
causes you to lose the insurance that you like . . . .”4 Amidst these 
political and societal tensions, the United States health care industry 
experienced monumental shifts in health care coverage, organiza-
tional and funding structures, and a fundamental understanding of 
the meaning of “health” in the United States.5 As policymakers and 
health care providers alike seek to achieve the “Triple Aim”6—com-
posed of “[i]mproving the patient experience of care . . . ; [i]mprov-
ing the health of populations; and [r]educing the per capita cost of 
health care”7—through the implementation of the various provisions 
of the ACA, one major organizational structure has garnered special 
attention: the Accountable Care Organization (“ACO”) models of 
care. 
Defined as “groups of doctors, hospitals, and other health care 
providers, who come together voluntarily to give coordinated high 
quality care to the Medicare patients they serve,”8 the ACO models 
                                                                                                             
4 (Mar. 31, 2011), http://www.nejm.org/doi/pdf/10.1056/NEJMp1103602 
(“Whatever form ACOs eventually take, one thing is certain: the era of frag-
mented care delivery should draw to a close. Too many Medicare beneficiaries—
like many other patients—have suffered at the hands of wasteful, ineffective, and 
poorly coordinated systems of care, with consequent costs that are proving unsus-
tainable.”). 
 4 Mitt Romney, Mitt Romney: I Will Repeal Obamacare, P2012.ORG (June 
28, 2012), http://www.p2012.org/issues/hc062812oppose.html; see also Robert 
B. Leflar, Reform of the United States Health Care System: An Overview, 10 U. 
TOKYO J.L. & POL. 44, 49 (2013) (Opponents of the ACA argued that the law 
“infringed on personal liberty and was beyond Congress’s power.”). 
 5 See generally PPACA, 124 Stat. 119 (codified as amended in scattered sec-
tions of 42 U.S.C.). 
 6 Inst. for Healthcare Improvement, The IHI Triple Aim Initiative, INST. 
HEALTHCARE IMPROVEMENT, http://www.ihi.org/engage/initiatives/tripleaim/Pa
ges/default.aspx (last visited Jan. 16, 2016) [hereinafter IHI Triple Aim] (describ-
ing a framework “to optimiz[e] health system performance” through the “Triple 
Aim.”). 
 7 IHI Triple Aim, supra note 6. See also Berwick, supra note 3, at 1 (“[The 
ACO’s] purpose is to foster change in patient care so as to accelerate progress 
toward a three-part aim: better care for individuals, better health for populations, 
and slower growth in costs through improvements in care.”). 
 8 Center for Medicare & Medicaid Services, Accountable Care Organiza-
tions (ACOs): General Information, CTRS. MEDICARE & MEDICAID SERVS. (Jan. 
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has been (skeptically)9 characterized as an organizational model 
likely to result in major cost savings for the Medicare program—
and the American health care system as a whole.10 While many stud-
ies generally paint a positive picture of the impact ACOs have had 
since their inception under the ACA,11 several questions remain un-
answered. 
This Comment hopes to shed light on the current state of the 
ACO model of care, while pointing to the remaining unanswered 
questions. In so doing, this Comment posits that, with respect to 
ACOs, the “Triple Aim”12 has been undone by the disproportionate 
emphasis on “restraining costs.”13 This financial focus overshadows 
the two remaining priorities of American health reform: improving 
quality of care and facilitating access to care through the ACO 
                                                                                                             
11, 2016), https://innovation.cms.gov/initiatives/aco/ [hereinafter ACOs: General 
Information]. 
 9 See Eleanor D. Kinney, The Affordable Care Act and the Medicare Pro-
gram: The Engines of True Health Reform, 13 YALE J. HEALTH POL’Y, L., & 
ETHICS 253, 295 (2013) (“Although the provider community was initially skepti-
cal of ACOs, . . . they have responded to the initiative relatively enthusiasti-
cally.”) (footnote omitted). 
 10 See Berwick, supra note 3, at 4 (“CMS believes that with enhanced coop-
eration among beneficiaries, hospitals, physicians, and other health care provid-
ers, ACOs will be an important new tool for giving Medicare beneficiaries the 
affordable, high-quality care they want, need, and deserve.”); Jenny Gold, Ac-
countable Care Organizations, Explained, KAISER HEALTH NEWS (Sept. 14, 
2015), http://khn.org/news/aco-accountable-care-organization-faq/ (“While 
ACOs are touted as a way to help fix an inefficient payment system that rewards 
more, not better, care, some economists warn they could lead to greater consoli-
dation in the health care industry . . . .”); Thomas L. Greaney, Regulators as Mar-
ket-Makers: Accountable Care Organizations and Competition Policy, 46 ARIZ. 
ST. L.J. 1, 1 (2014) (“The ACO strategy entails regulatory interventions that at 
once aim to reshape the health care delivery system, improve outcomes, promote 
adoption of evidence-based medicine and supportive technology, and create a 
platform for controlling costs under payment system reform.”). While multiple 
ACO models exist, this Comment will refer to them collectively as the “ACO 
model of care.” 
 11 Interestingly, the ACO model of care did not originate from the ACA. See 
Paul R. DeMuro, Accountable Care, 24 HEALTH L. 1, 11 (2012) (“ACOs are not 
uniquely a convention of the Medicare program and have existed in some form 
for a number of years. In fact, many provider/health plan ‘partnerships’ are in the 
form of . . . [commercial] ACOs.”). 
 12 IHI Triple Aim, supra note 6. 
 13 Leflar, supra note 4, at 49. 
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model of care.14 This Comment advocates for a rebalancing of pri-
orities to achieve the original tri-mission of expanded access, im-
proved quality, and reduced costs within the new, post-ACA Amer-
ican health care system. 
Part I begins with an overview of the statutory definition, phi-
losophy and values, and various organizational structures currently 
in place for ACOs. Following this foundational description of the 
ACO model of care, this Comment will consider three perspectives 
in the overall discussion of ACOs, all of which are within the frame-
work of the “Triple Aim.”15 Part II considers the first of these per-
spectives—reducing overall costs within the American health sys-
tem—by exploring the idea of “bending the cost curve,” and the gen-
eral ability of the ACO model to reduce costs under the current Med-
icare system and beyond. Part III critically reviews the grading 
methodology used to achieve the second perspective in the trian-
gle—quality of care provided—and asks whether this methodology 
is accurately structured to achieve true improvements in quality of 
care. Part IV considers the third perspective of the “Triple Aim”16—
expanding access to care—and evaluates whether ACOs have met 
that goal. This Comment concludes with final thoughts on the gen-
eral success of, as well as the future trajectory, of the ACO model 
of care. 
I. ACCOUNTABLE CARE ORGANIZATIONS: PHILOSOPHY, STATUTE, 
AND ORGANIZATION 
Though the ACO model of care has become a popularized prod-
uct of the ACA,17 the concept of the ACO generally existed in one 
form or another prior to the passage of the ACA.18 However, be-
cause of the passage of the ACA, the ACO model has become one 
of the more lucrative, incentive-based programs for health care pro-
viders.19 For policymakers, the concept of the ACO fits nicely in the 
                                                                                                             
 14 Id. 
 15 IHI Triple Aim, supra note 6. 
 16 IHI Triple Aim, supra note 6. 
 17 See, e.g., Gold, supra note 10 (“ACOs have become one of the most talked 
about new ideas in . . . [the ACA].”). 
 18 DeMuro, supra note 11, at 1, 11. 
 19 Part II provides a detailed discussion of the payment methods used to re-
ward ACOs for savings generated. See generally infra Part II. 
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shifting framework, goals, and values of the new post-ACA Ameri-
can health care system.20 
Defined as “a group of primary care doctors, specialists, hospi-
tals, and other health care providers, who come together with a com-
mon goal of delivering high-quality coordinated care to their Medi-
care patients,”21 the ACO model of care aims to balance the “Triple 
Aim”22 by implementing a “carrot-and-stick approach” to care.23 Es-
sentially, the ACO model creates a multi-team system of care in 
which overall reductions in cost and general improvements in qual-
ity care are rewarded.24 At least 744 ACOs have been created since 
2011, both privately and through public programs created through 
Medicare.25 While strategies of implementation vary among ACOs, 
                                                                                                             
 20 Greaney, supra note 10, at 4 (“The MSSP attempts to tackle this policy 
quandary [of changing the payment and delivery system of the health care system] 
by addressing both problems simultaneously, offering financial rewards to pro-
viders that organize and reorient their practices to deliver seamless, high quality 
care.”). 
 21 Robert Tagalicod, Accountable Care Organizations: The Future of Coor-
dinated Care, CTRS. MEDICARE & MEDICAID SERVS. (Aug. 23, 2013, 2:33 PM), 
https://www.cms.gov/eHealth/ListServ_AccoutableCareOrgs.html; Kinney, su-
pra note 9, at 294 (“CMS defines ACOs as ‘groups of doctors, hospitals, and other 
health care providers, who come together voluntarily to give coordinated high 
quality care to their Medicare patients.’”); see also Song, supra note 1, at 364 
(“Three key characteristics are embedded in this definition. First is joint account-
ability. . . . Second, an ACO takes on accountability for both spending and qual-
ity. . . . Third, an ACO is responsible for the care of a population of people.”). 
 22 IHI Triple Aim, supra note 6. 
 23 Gold, supra note 10 (“The law takes a carrot-and-stick approach by en-
couraging the formation of . . . [ACOs] in the Medicare program. Providers make 
more if they keep their patients healthy.”). 
 24 Berwick, supra note 3, at 1 (“Under the law, an ACO will assume respon-
sibility for the care of a clearly defined population of Medicare beneficiaries at-
tributed to it on the basis of their patterns of use of primary care. If an ACO suc-
ceeds in both delivering high-quality care and reducing the cost of that care to a 
level below what would otherwise have been expected, it will share in the Medi-
care savings it achieves.”); Song, supra note 1, at 368 (“ACOs serve as a vehicle 
for payment reform and organizational reform among providers. They bring phy-
sicians across specialties and hospitals together under the same contractual roof, 
allowing the organization to determine how it allocates its resources under the 
spending target.”). 
 25 Gold, supra note 10 (“About 6 million Medicare beneficiaries are now in 
an ACO, and, combined with the private sector, at least 744 organizations have 
become ACOs since 2011. An estimated 23.5 million Americans are now being 
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the ACA provides a general statutory framework to guide the for-
mation, goals, values, and organizational functioning of ACOs in 
the United States.26 
A. Statutory Definition of ACOs Under the Affordable Care 
Act 
Buried in the long list of reforms and policy strategies within the 
ACA, Title III27—titled “Improving the Quality and Efficiency of 
Health Care”—is the formulaic attempt to balance the “Triple Aim” 
for beneficiaries participating in the Medicare program.28 This title 
aims to 1) improve quality of care and 2) more efficiently deliver 
care by reforming the payment structures, quality standards, deliv-
ery methods, and organizational models through which Medicare 
beneficiaries receive care.29 Of the seven subtitles under Title III, 
subtitle A forms the statutory basis for generally achieving the “Tri-
ple Aim”: Part I influences the current cost structures; Part II ad-
dresses the quality of care provided; and Part III targets the effi-
ciency of care.30 Specifically, Part III outlines in detail the ACO 
model of care through the Medicare Shared Savings Program.31 
                                                                                                             
served by an ACO.”); Terry L. Corbett, Healthcare Corporate Structure and the 
ACA: A Need for Mission Primacy Through a New Organizational Paradigm?, 
12 IND. HEALTH L. REV. 103, 162 (2015) (“[T]he ACA does not prohibit the de-
velopment of ‘private’ ACOs, which are free to organize and operate independent 
of the Medicare Program. In theory, at least for now, such ACOs could operate 
entirely as for-profit enterprises relying solely on reimbursement from non-gov-
ernmental, third-party payors . . . .”). See generally Valerie A. Lewis et al., Ac-
countable Care Organizations in the United States: Market and Demographic 
Factors Associated with Formation, 48 HEALTH SERVS. RES. 1840, 1849–53 
(2013) (providing visual and descriptive results of the number of ACOs across 
various geographical regions); David Muhlestein, Growth And Dispersion Of Ac-
countable Care Organizations In 2015, HEALTH AFF. BLOG (Mar. 31, 2015), http:
//healthaffairs.org/blog/2015/03/31/growth-and-dispersion-of-accountable-care-
organizations-in-2015-2/ (Section titled “ACO Growth,” which describes the in-
crease in the number of ACOs since 2011 when ACO contracts began). 
 26 See infra Part I, section A, subsection 3; Part. I, section C. 
 27 PPACA, tit. III, 124 Stat. at 353–538. 
 28 See generally id. 
 29 See id. 
 30 PPACA, tit. III, subtit. A, pt. I–III, 124 Stat. at 353–415. 
 31 Id. at pt. III, 124 Stat. at 389–415. 
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1. SUBTITLE A, PART III: ENCOURAGING DEVELOPMENT OF 
NEW PATIENT CARE MODELS 
Subtitle A, Part III32 is “designed to make the delivery of, and 
payment for, health care services to Medicare fee-for-service bene-
ficiaries more integrated and efficient and therefore, less costly.”33 
This part of Subtitle A establishes the Center for Medicare and Med-
icaid Innovation (“CMI”) within the Centers for Medicare and Med-
icaid Services (“CMS”), as well as several incentive programs for 
health care providers of varying size and experience to participate 
in the twin goals of Title III: improving quality and efficiency.34 In 
effect, Part III creates a national laboratory for creating, testing, and 
refining models of care consistent with the “Triple Aim.”35 
2. SECTION 3021: ESTABLISHMENT OF CENTER FOR MEDICARE 
AND MEDICAID INNOVATION WITHIN CENTER FOR 
MEDICARE AND MEDICAID SERVICES 
Section 3021 outlines the mission and objectives of the CMI, the 
research arm used to identify and test models that best reduce the 
cost of care while improving quality.36 The CMI “test[s] innovative 
payment and service delivery models to reduce program expendi-
tures . . . while preserving or enhancing the quality of care furnished 
to individuals.”37 Based on the research results produced from “con-
sult[ing] representatives of relevant Federal agencies, and clinical 
and analytical experts with expertise in medicine and health care 
management,”38 the Secretary of the Department of Health and Hu-
man Services (“Secretary”) will “give preference to models that . . . 
                                                                                                             
 32 PPACA, tit. III, subtit. A, pt. III, secs. 3021–27, 124 Stat. at 389–415. 
 33 Kinney, supra note 9, at 292. 
 34 See PPACA, tit. III, subtit. A, pt. III, sec. 3021, 124 Stat. at 389–95. 
 35 See Centers for Medicare & Medicaid Services, Innovation Center, CTRS. 
MEDICARE & MEDICAID SERVS., https://innovation.cms.gov (last visited Jan. 29, 
2016). 
 36 42 U.S.C. § 1315a (2012); David Blumenthal et al., The Affordable Care 
Act at 5 Years, 372 NEW ENG. J. MED. 2451, 2455 (2015) (“Funded at $1 billion 
per year for 10 years, CMMI has the authority to undertake a wide variety of ex-
periments for the purpose of improving quality and reducing cost within the Med-
icare and Medicaid Programs.”). 
 37 42 U.S.C. § 1315a(a)(1). 
 38 Id. at (a)(3). 
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improve the coordination, quality, and efficiency of health care ser-
vices furnished to applicable individuals.”39 The Secretary selects 
models based on “evidence that the model addresses a defined pop-
ulation for which there are deficits in care leading to poor clinical 
outcomes or potentially avoidable expenditures.”40 Successful mod-
els may be expanded on a national scale in order to further the twin 
goals of improving quality and efficiency of care.41 
3. SECTION 3022: MEDICARE SHARED SAVINGS PROGRAM 
As a separate initiative, Section 3022 creates the Medicare 
Shared Savings Program (“MSSP”), the program through which the 
ACO initiative exists.42 The MSSP aims to “promote[] accountabil-
ity for a patient population and coordinate[] items and services . . . , 
and encourages investment in infrastructure and redesigned care 
processes for high quality and efficient service delivery.”43 To do 
so, the MSSP sets a broad model of participation such that: 
(A) groups of providers of services and suppliers 
meeting criteria specified by the Secretary may work 
together to manage and coordinate care for Medicare 
fee-for-service beneficiaries through an accountable 
care organization . . . ; and 
(B) ACOs that meet quality performance standards 
established by the Secretary are eligible to receive 
payments for shared savings . . . .44 
Under this provision, groups of health care providers who meet 
the eligibility requirements may receive payment for shared savings 
earned for meeting defined performance standards by coordinating 
                                                                                                             
 39 Id. at (a)(1). 
 40 Id. at (b)(2)(A). 
 41 Blumenthal et al., supra note 36, at 2455 (“This new capability to spread 
proven programs quickly could markedly enhance the nimbleness of federal pol-
icymaking.”). 
 42 42 U.S.C. § 1395jjj. 
 43 42 U.S.C. § 1395jjj(a)(1). 
 44 42 U.S.C. § 1395jjj(a)(1)(A)–(B); Frank Pasquale, Accountable Care Or-
ganizations in the Affordable Care Act, 42 SETON HALL L. REV. 1371, 1372 
(2012) (“The MSSP is an incentive program, not a mandate: the private sector 
must choose to participate if it is to be effective.”). 
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the overall care of Medicare beneficiaries assigned to the ACO by 
the Secretary.45 Eligibility is determined based on whether the group 
of providers “have established a mechanism for shared govern-
ance,”46 though Section 3022 does not require any particular struc-
ture of governance.47 
However, all participating ACOs must meet the following eight 
general requirements that help define and guide the operation of an 
ACO: 1) a willingness “to become accountable for the quality, cost, 
and overall care of the Medicare fee-for-service beneficiaries as-
signed” to the ACO; 2) a formal contract of no less than three years 
entered with the Secretary; 3) a formal legal structure that allows 
“the organization to receive and distribute payments for shared sav-
ings”; 4) a minimum number of Medicare fee-for-service beneficiar-
ies that the ACO serves (at least 5,000), as well as primary care phy-
sicians; 5) the provision of necessary information to the Secretary to 
aid in the assigning of Medicare fee-for-service beneficiaries, as 
well as “the implementation of quality and other reporting require-
ments”; 6) a leadership and management structure “that includes 
clinical and administrative systems”; 7) a process “to promote evi-
dence-based medicine and patient engagement, report on quality and 
                                                                                                             
 45 See 42 U.S.C. § 1395jjj(a)(1)(A)–(B); id. at (c) (“The Secretary shall de-
termine an appropriate method to assign Medicare fee-for-service beneficiaries to 
an ACO based on their utilization of primary care services provided . . . by an 
ACO professional.”). 
 46 42 U.S.C. § 1395jjj(b)(1)(A)–(E); Louise Walling, Joining an ACO? Ques-
tions to ask before you sign, 4 TEX. MED. LIABILITY TR. 1, 2 (2013). 
 47 Centers for Medicare & Medicaid Services, Shared Savings Program, 
CTRS. MEDICARE & MEDICAID SERVS. (Dec. 20, 2015, 11:50 AM), https://www.
cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/in
dex.html?redirect=/sharedsavingsprogram/ (last visited Jan. 13, 2016) [hereinaf-
ter Shared Savings Program] (“Participation in an ACO is purely voluntary.”); 
Corbett, supra note 25, at 160 (“By design, the ACA has not specified any partic-
ular legal or organizational form through which these multiple stakeholders are to 
accomplish the requisite ‘shared governance’ of the ACO.”). Section 3022 does 
articulate a select group of providers that will be eligible to participate; however, 
it also includes a catch-all provision that states that “[s]uch other groups of pro-
viders of services and suppliers as the Secretary determines appropriate” may par-
ticipate, leaving the “shared governance” structure broad. See 42 U.S.C. 
§ 1395jjj(b)(1)(A)–(E). 
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cost measures, and coordinate care”; and 8) an ability to “demon-
strate to the Secretary that . . . [the ACO] meets patient-centeredness 
criteria specified by the Secretary.”48 
These general requirements are coupled with quality and report-
ing requirements, established to determine the overall reduction of 
costs and improvement in quality and efficiency of care that an ACO 
provides in a given year.49 These quality and reporting requirements 
are established by the Secretary in conjunction with quality perfor-
mance standards designed “to assess the quality of care furnished 
by . . . ACO[s],”50 with quality standards improving over time “by 
specifying higher standards, new measures, or both . . . .”51 This in-
formation is collected by the ACO during a given year and then sub-
mitted to the Secretary in order “to evaluate the quality of care fur-
nished by the ACO.”52 The information collected can range from 
“clinical processes and outcomes” to “patient and . . . caregiver ex-
perience of care,” as well as “utilization.”53 
In exchange for meeting these quality and cost-saving require-
ments, participating ACOs are eligible to receive a payment of 
“shared savings.”54 Such “shared savings” are calculated as “a per-
cent . . . of the difference between . . . [the] estimated average per 
                                                                                                             
 48 See 42 U.S.C. § 1395jjj(b)(2)(A)–(H); Corbett, supra note 25, at 160 
n.296; The Dartmouth Institute for Health Policy & Clinical Practice, What is an 
ACO, DARTMOUTH INST. HEALTH POL’Y & CLINICAL PRAC., http://tdi.dart-
mouth.edu/research/evaluating/health-system-focus/accountable-care-organiza-
tions/about-us (last visited Jan. 13, 2016) [hereinafter Dartmouth Institute] (Ar-
ticulating that all ACOs must be capable of: 1) “Providing or managing the con-
tinuum of care for patients as a real or virtually integrated delivery system”; 2) 
“Supporting comprehensive performance measurement and expenditure projec-
tions”; 3) “Internally distributing shared savings and prospectively planning 
budgets and resource needs.”); DeMuro, supra note 11, at 3–5 (listing the foun-
dational elements of an accountable care organization, including: “Patient-Cen-
tered Medical Homes”; “Cross-Collaborative Team Approach to Care”; “Strong 
Foundation of High-Performing Primary Care”; “Ability to Measure Quality”; 
“Evidence-Based Medicine”; “Transparency”; “Health Information Technology”; 
“Culture of Accountability”; “Integrating Independent Physicians”; and “Tele-
medicine and E-Health.”). 
 49 See 42 U.S.C. § 1395jjj(b)(3)(A)–(D). 
 50 Id. at (b)(3)(A). 
 51 Id. at (b)(3)(C). 
 52 Id. at (b)(3)(B). 
 53 See id. at (b)(3)(A)(i)–(iii). 
 54 Id. at (d)(1)(A). 
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capita Medicare expenditures in a year”55 and a benchmark set by 
the Secretary,56 with limits to the total amount of shared savings an 
ACO is able to receive.57 This benchmark is set “using the most re-
cent available [three] years of per-beneficiary expenditures for . . . 
services for Medicare fee-for-service beneficiaries assigned to the 
ACO” and is adjusted both annually and to the characteristics of 
each beneficiary.58 A provider or supplier’s original payments under 
the Medicare fee-for-service program remain unaltered;59 rather, the 
shared savings incentive is an additional payment that may be 
earned by participating ACOs that meet the quality performance 
standards and general ACO requirements.60 However, the Secretary 
maintains the discretion to terminate contracts with ACOs that do 
not meet the quality performance standards,61 as well as impose 
sanctions on ACOs that attempt to reduce costs by avoiding at-risk 
patients.62 
Alternatively, the Secretary may choose to use a payment model 
other than the shared savings model for making payments to partic-
ipating ACOs.63 The first of these alternatives is a partial capitation 
model in which the participating ACO “is at financial risk for some, 
but not all, of the items and services covered.”64 This payment model 
is typically limited to advanced health systems best able to bear the 
risk.65 The second alternative allows for the Secretary to implement 
a payment model “that the Secretary determines will improve the 
quality and efficiency of items and services furnished” by the par-
ticipating ACO.66 In both these alternatives, the payment model 
                                                                                                             
 55 Id. at (d)(2). 
 56 Id. at (d)(1)(B)(ii). 
 57 Id. at (d)(2). 
 58 Id. at (d)(1)(B)(ii). 
 59 Id. at (d)(1)(A) (original payments by Medicare are “made to providers of 
services and suppliers participating in an ACO, under the original Medicare fee-
for-service program.”). 
 60 Id. 
 61 Id. at (d)(4). 
 62 Id. at (d)(3). 
 63 Id. at (i)(1). 
 64 Id. at (i)(2)(A). 
 65 Id. at (i)(2)(A) (this payment model is limited to “ACOs that are highly 
integrated systems of care and . . . [are] capable of bearing risk.”). 
 66 Id. at (i)(3)(A). 
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must not be designed to cause more spending towards the participat-
ing ACO than would have been spent for the ACO under a normal 
payment model.67 
B. Philosophy and Vision for ACOs 
The ACA and the rapid move to the ACO model of care reflects 
a national desire to increase health coverage for all Americans while 
reducing the cost of care in the United States.68 These national aims 
are encapsulated in the “Triple Aim”69—increasing access to care, 
reducing cost of care, and improving quality of care70—which mir-
ror the goal of the ACO model of care71—“to be accountable for the 
overall cost and quality for a full spectrum of care for a defined pop-
ulation.”72 ACOs are driven by three philosophical principles that 
align with the “Triple Aim”: 1) “Local Accountability” by assigning 
the patient to the ACO where they receive the greatest number of 
services, but without requiring the patient to only go to the assigned 
ACO; 2) “Shared Savings” that ACOs may earn when quality stand-
                                                                                                             
 67 Id. at (i)(2)(B), (i)(3)(B). 
 68 Leflar, supra note 4, at 49. 
 69 IHI Triple Aim, supra note 6. 
 70 Berwick, supra note 3, at 1; Leflar, supra note 4, at 49 (quotations re-
moved). 
 71 Ellen Josephine Angelo, Accountable care organizations: Are they the 
right answer?, 42 NURSING MGMT. 20, 22 (2011) (“The goal of the ACO is to pay 
providers . . . utilizing a methodology that encourages the team to collaboratively 
work together and share accountability based on efficiency and high quality ex-
ceeding national benchmarks.”). 
 72 Dartmouth Institute, supra note 48. See also Angelo, supra note 71; Ber-
wick, supra note 3, at 1; Greaney, supra note 10, at 5–6 (“[T]he core concept [of 
an ACO] envisions a local entity and a related set of providers, including primary 
care physicians, specialists, and hospitals that can be held accountable for the cost 
and quality of the entire continuum of care delivered to a defined popula-
tion . . . .”); Peter Wehrwein, An Accounting of ACOs: Where they are, what they 
are, and how many there are, MANAGED CARE MAG. ONLINE (Nov. 2014), http://
www.managedcaremag.com/linkout/2014/11/26 (defining ACOs as “a provider-
led organization that takes on the financial risk for the health care of a defined 
population.”). 
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ards are met and costs are reduced; and 3) “Performance Measure-
ment[s]” which ACOs must collect to monitor overall perfor-
mance.73 
An ACO “itself has a fiduciary obligation to the patients it serves 
comparable to that historically attributed only to physicians,” ex-
tending this “well-established [duty] in the profession of medicine 
‘to all major participants in the health care industry’ . . . involved in 
the direct delivery of health care services to patients.”74 This stand-
ard in turn shifts the control element from insurers to providers of 
care because beneficiaries are assigned to ACOs based on usage ra-
ther than on plan selection.75 Along with this fiduciary obligation, 
ACOs are held to a level of accountability through the measures and 
quality reporting requirements, as well as the requirement to control 
costs.76 Similarly, the ACO model of care is intended to shift the 
payment model from one of fee-for-service to one based on deliver-
ing the highest quality care at the lowest price possible.77 By setting 
a fiduciary obligation and an accountability measure on participat-
ing ACOs, along with a restructured payment model, the intention 
is for the ACO to fix the fragmented American health system that 
currently lacks coordination and communication.78 
                                                                                                             
 73 Dartmouth Institute, supra note 48. See also Pasquale, supra note 44, at 
1374 (Describing “the ‘three key attributes’ of ACOS [as]: ‘organized care, per-
formance measurement, and payment reform.’”). 
 74 Corbett, supra note 25, at 177. 
 75 Greaney, supra note 10, at 7–8 (Noting the distinction between Health 
Management Organizations (“HMOs”) and ACOs, including that beneficiaries 
are assigned to a specific ACO whereas beneficiaries are not assigned to HMOs). 
 76 DeMuro, supra note 11, at 1 (the ACO “understand[s] that care will be 
measured and reported and that quality must improve, all while costs are con-
trolled, or at least monitored.”) (internal quotation marks omitted). 
 77 Michealle Gady & Marc Steinberg, Making the Most of Accountable Care 
Organizations (ACOs): What Advocates Need to Know, FAMILIES USA 1, 2 (Feb-
ruary 2012), http://familiesusa.org/sites/default/files/product_documents/ACO-
Basics.pdf (“One of the goals of ACOs is to move the health care system away 
from a fee-for-service system, in which providers are paid for each service a pa-
tient receives, to one focused on delivering the best care at the best price.”). This 
is discussed in further detail in Part III. See infra Part III, section A. 
 78 Gady & Steinberg, supra note 77, at 2 (“ACOs aim to fix the fragmentation 
in our health care system by addressing simultaneously both the way care is de-
livered . . . and the way that it is paid for . . . .The ACO should help bridge the gap 
in communication that has often existed between providers . . . [and] health care 
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C. Organizational Structures of ACOs 
While several models of ACOs have been promulgated and 
tested since the passage of the ACA,79 three major models have 
arisen through CMS. They vary based on their contractual structure, 
organizational development, and payment method.80 These three 
major models include the Medicare Shared Savings Program, the 
Pioneer ACO Model, and the Advanced Payment ACO Model. 
1. MEDICARE SHARED SAVINGS PROGRAM 
Of the major ACO models created and tested, MSSP is currently 
one of the largest initiatives serving fee-for-service Medicare bene-
ficiaries.81 Under this “new approach to the delivery of health 
care,”82 participating organizations must meet quality performance 
standards set forth by the Secretary while generating savings in or-
der to qualify for the percentage of the “shared savings” from the 
Medicare program.83 Shared savings are determined by calculating 
the difference between the dollar amount spent per patient in a given 
                                                                                                             
providers.”); Gold, supra note 10 (“ACOs are touted as a way to help fix an inef-
ficient payment system that rewards more, not better, care . . . .”); Greaney, supra 
note 10, at 1 (“The ACO strategy entails regulatory interventions that at once aim 
to reshape the health care delivery system, improve outcomes, promote adoption 
of evidence-based medicine and supportive technology, and create a platform for 
controlling costs under payment system reform.”). See Berwick, supra note 3, at 
1 (“A common criticism of U.S. health care is the fragmented nature of its pay-
ment and delivery systems [in which] . . . no single group of participants . . . takes 
full responsibility for guiding the health of a patient or community . . . .Fragmen-
tation leads to waste and duplication—and unnecessarily high costs.”). 
 79 See ACOs: General Information, supra note 8 (“ACO Programs at CMS”). 
 80 See id. 
 81 Association of State and Territorial Health Officials, Accountable Care Or-
ganizations and Public Health, ASS’N ST. & TERRITORIAL HEALTH OFFICIALS 1, 
2 (2013), http://www.astho.org/programs/access/primary-care/_materials/aco-
and-public-health-fact-sheet/ [hereinafter ASTHO] (“One of the largest ACO ini-
tiatives . . . [a]s of September 2012, MSSP selected 116 organizations . . . to par-
ticipate in the program.”). See Shared Savings Program, supra note 47. 
 82 Shared Savings Program, supra note 47. 
 83 ASTHO, supra note 81, at 2; Shared Savings Program, supra note 47 
(“[T]he Shared Savings Program aims to improve [Medicare fee-for-service] ben-
eficiary outcomes and increase value of care . . . [by] reward[ing] ACOs that 
lower their growth in health care costs while meeting performance standards on 
quality of care and putting patients first.”). 
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year and the national benchmark set by the government, which rep-
resents the amount of health care dollars allocated per patient per 
year.84 If the amount calculated is less than the national benchmark, 
the ACO experiences a “shared savings,” of which the Medicare 
program will pay back a percentage to the participating ACO.85 
However, ACOs in the MSSP do not face shared risk for exceeding 
the national benchmark due to the contractual relationship created—
the so called “one-sided ACO contract.”86 Reducing the cost of care 
alone is insufficient; rather, the quality of care the ACO coordinates 
and provides must improve, based on thirty-three quality measures 
across four domains.87 As the quality of care improves and the health 
                                                                                                             
 84 Walling, supra note 46, at 1–2. This national benchmark that the ACO as-
sumes as its spending target “usually takes into account its historical cost trends 
and the burden of morbidity among its patients.” Song, supra note 1, at 364. 
 85 Walling, supra note 46, at 2; Song, supra note 1, at 364–65. (manuscript at 
2) (“If spending for [the ACO’s]. . . patient population ends up below the target 
by at least a minimum amount, the organization receives a share of the savings. If 
the spending exceeds the target. . . the organization may not be reimbursed a por-
tion of the difference.”). The percentage earnable under a one-sided contract is 50 
percent of the savings generated. See Centers for Medicare & Medicaid Services, 
Guide to Quality Performance Scoring Methods for Accountable Care Organiza-
tions, CTRS. MEDICARE & MEDICAID SERVS. 1, 4 (2012), https://www.cms.gov/
medicare/medicare-fee-for-service-payment/sharedsavingsprogram/downloads/2
012-11-aco-quality-scoring-supplement.pdf [hereinafter Guide to Quality Perfor-
mance]. 
 86 Song, supra note 1, at 365 (“In a so-called one-sided ACO contract—the 
majority of those in the . . . [MSSP]—organizations face only shared savings but 
do not face shared risk.”); McClellan et al., A National Strategy To Put Account-
able Care Into Practice, 29 HEALTH AFF. 982, 984 (2010) (“[A] ‘one-sided’ 
shared-savings model . . . would entail no performance risk to providers even if 
they experience higher costs or if they do not achieve quality performance 
goals.”). 
 87 Centers for Medicare & Medicaid Services, The Affordable Care Act: 
Helping Providers Help Patients, CTRS. MEDICARE & MEDICAID SERVS. 1, 2, 
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ACO/downl
oads/ACO-Menu-Of-Options.pdf (last visited Jan. 13, 2016) [hereinafter A Menu 
of Options] (“These [four] domains include patient, experience, care coordination 
and patient safety, preventive health[,] and at-risk populations.”). See generally 
Centers for Medicare & Medicaid Services, Quality Measures and Performance 
Standards, CTRS. MEDICARE & MEDICAID SERVS. (Mar. 2, 2015), https://www.
cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Q
uality_Measures_Standards.html (providing information and resources on the 
thirty-three current quality measures). Quality measures and domains are dis-
cussed in detail in Part III. See infra Part III, section A. 
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expenditures decrease, the ACO will experience a greater amount of 
shared savings.88 
2. PIONEER ACO MODEL 
The second of the ACO models is a more advanced model “de-
signed for health care organizations and providers that are already 
experienced in coordinating care for patients across care settings.”89 
Unlike other ACO initiatives, Pioneer ACOs allow “provider groups 
to move more rapidly from a shared savings payment model to a 
population-based payment model . . . [that is] flexible to accommo-
date [to] the specific organizational and market conditions in which 
[the] Pioneer ACOs work.”90 Similar to other ACO models, Pioneer 
ACOs work to improve quality of care and health outcomes pro-
vided to Medicare beneficiaries, while reducing the cost of care for 
all paying actors.91 Unlike the MSSP ACOs, Pioneer ACOs enter a 
“two-sided contract” in which the participating ACO faces “both 
                                                                                                             
 88 A Menu of Options, supra note 87, at 2 (“The higher the quality of care 
providers deliver, the more shared savings their Accountable Care Organization 
may earn, provided they also lower growth in health care expenditures.”). 
 89 Centers for Medicare & Medicaid Services, Pioneer ACO Model, CTRS. 
MEDICARE & MEDICAID SERVS. (Dec. 07, 2015), https://innovation.cms.gov/ini-
tiatives/Pioneer-ACO-Model/index.html [hereinafter Pioneer ACO Model] (last 
visited Sept. 26, 2016); ASTHO, supra note 81, at 2 (“The Pioneer Model was 
designed for organizations with previous experience operating in ACO-like ar-
rangements with coordinated, patient-centered care.”); A Menu of Options, supra 
note 87, at 2 (“The Pioneer model is an initiative complementary to the 
[MSSP] . . . designed for organizations with experience providing integrated care 
across settings.”); Kinney, supra note 9, at 294 (“The Pioneer ACO Model was 
designed specifically for organizations with ‘experience offering coordinated, pa-
tient-centered care, and operating in ACO-like arrangements.’”). 
 90 Pioneer ACO Model, supra note 89; A Menu of Options, supra note 87, at 
2 (“The Pioneer Model tests a rapid transition to a population-based model of care, 
and engages other payers in moving toward outcomes-based contracts.”); ASTHO, 
supra note 81, at 2 (The Pioneer ACO Model “will allow these provider groups 
to move more rapidly from a shared savings payment model to a population-based 
payment model.”). 
 91 Pioneer ACO Model, supra note 89 (The Pioneer ACO Model aligns “pro-
vider incentives, which will improve quality and health outcomes for patients 
across the ACO, and achieve cost savings for Medicare, employers[,] and pa-
tients.”). 
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shared savings and shared risk,” but enjoys potentially higher re-
turns for meeting quality measures and cost reductions.92 Savings 
received or losses owed in a given year are based on whether the 
ACO’s expenditures are “outside a minimum corridor set by the 
ACO’s minimum savings rate (MSR) and minimum loss rate 
(MLR).”93 While the program began with thirty-two Pioneer 
ACOs,94 the program currently has nine participating ACOs.95 
3. ADVANCED PAYMENT ACO MODEL 
The Advanced Payment ACO Model arose out of stakeholder 
concerns regarding their lack of available capital to invest in infra-
structure and staff needed to provide the high-quality care demanded 
of participating ACOs.96 Under the Advanced Payment ACO 
Model, participating ACOs—typically smaller ACOs formed by 
physician-owned and rural providers97—receive an upfront, 
                                                                                                             
 92 McClellan et al., supra note 86, at 984 (“Also possible are ‘two-sided’ or 
‘symmetric’ payment models that would give providers an opportunity to receive 
proportionately larger bonus payments in exchange for accountability for costs 
that greatly exceed preset goals.”); Song, supra note 1, at 365.The percentage 
earnable under a two-sided contract is sixty percent of the savings generated. See 
Guide to Quality Performance, supra note 85, at 4. 
 93 Pioneer ACO Model, supra note 89 (“If savings/loss is within this corridor, 
no payment is made to the ACO or owed to CMS. If the Gross Savings/Losses 
percentage is outside this corridor, then the ACO splits the overall savings/loss 
with CMS.”). 
 94 ASTHO, supra note 81, at 2 (As of 2013, “[t]hirty-two ACOs [were] . . . 
participating in the Pioneer ACO Model.”); Kinney, supra note 9, at 294 (As of 
2013, “[t]here [were] thirty-two organizations participating in the Pioneer ACO 
Model.”). 
 95 See Pioneer ACO Model, supra note 89. This decrease in the number of 
participating ACOs is likely due to the high standards required to share in savings 
generated. See, e.g., Peter Wehrwein, Pioneer ACOs: Some Unhitch Wagons 
While Others Roll Over Rocky Terrain, MANAGED CARE MAG. ONLINE (Oct. 
2014), http://www.managedcaremag.com/linkout/2014/10/43. See also infra Part 
II, section A, subsection 1; note 138, 151–52. 
 96 Centers for Medicare & Medicaid Services, Advance Payment ACO Model, 
CTRS. MEDICARE & MEDICAID SERVS. (Jan. 11, 2016), https://innovation.cms.
gov/initiatives/Advance-Payment-ACO-Model/index.html (last visited Sept. 26, 
2016) [hereinafter Advance Payment ACO Model] (“In developing the Advance 
Payment ACO Model, CMS is responding to input from stakeholders . . . [who] 
expressed a concern about their lack of ready access to the capital needed to invest 
in infrastructure and staff for care coordination.”). 
 97 Kinney, supra note 9, at 294. 
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monthly payment in “advance [of] the shared savings they are ex-
pected to earn” to support start-up costs and infrastructure-build-
ing.98 In return, CMS recovers the advance payments through the 
shared savings experienced by the ACO.99 ACOs participating in 
this model of care receive three types of payments, which 
“acknowledge that new ACOs will have both fixed and variable 
start-up costs”100: 1) an upfront, fixed payment received by each 
ACO; 2) an upfront, variable payment that is based on the number 
of historically-assigned beneficiaries to the ACO; and 3) a monthly 
payment that varies based on the size of the ACO and the number of 
historically-assigned beneficiaries to the ACO.101 Through this pay-
ment structure, the Advanced Payment ACO Model allows “physi-
cian-based and rural providers [participating in MSSP] . . . [to] 
come together voluntarily to give coordinated high quality care to 
the Medicare patients they serve.”102 There are currently thirty-five 
participants under this ACO model.103 
II. PERSPECTIVE #1: “BENDING THE COST CURVE” THROUGH ACOS 
The first perspective considers whether the ACO model are able 
to truly have a cost-cutting impact on the general rise in health care 
costs experienced in America over the past several decades. As a 
                                                                                                             
 98 Advance Payment ACO Model, supra note 96 (“Through the Advance Pay-
ment ACO Model, selected participants will receive upfront and monthly pay-
ments, which they can use to make important investments in their care coordina-
tion infrastructure . . . .[S]elected organizations will receive an advance on the 
shared savings they are expected to earn.”); Kinney, supra note 9, at 294 (“The 
Advanced Payment ACO Model provides additional support to physician-owned 
and rural providers who would benefit from additional start-up resources to build 
the necessary infrastructure, such as new staff or information technology sys-
tems.”). 
 99 A Menu of Options, supra note 87, at 2 (“The advance payments would be 
recovered from shared savings achieved by the Accountable Care Organization.”). 
 100 Advance Payment ACO Model, supra note 96 (“Advance payments are 
structured . . . to acknowledge that new ACOs will have both fixed and variable 
start-up costs.”). 
 101 Advance Payment ACO Model, supra note 96 (“Initiative Details”). 
 102 Advance Payment ACO Model, supra note 96. See ASTHO, supra note 81, 
at 2 (“The Advance Payment ACO Model will provide additional support to phy-
sician-owned and rural providers participating in the Shared Savings Pro-
gram . . . .”). 
 103 Advance Payment ACO Model, supra note 96. 
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cost-generating enterprise, “ACOs can be seen as an attempt to mit-
igate market and regulatory failures that pervade the financing and 
delivery of health care services.”104 This section will consider 
whether, in reality, ACOs are able to have such a pervasive effect 
on the overall costs of health care in the United States, or whether 
this model of care can only have a small effect on spending. Once 
“bending the cost curve” is defined, the cost-cutting effects of ACOs 
will be considered, ending with a survey of suggested approaches to 
further reduce costs through the ACO model of care. 
A. What Does It Mean to “Bend the Cost Curve?” 
Understanding the theory of “bending the cost curve” in the con-
text of the ACO begins with a consideration of the overall growth in 
spending within the American health care system since the creation 
of the Medicare and Medicaid programs in the late 1960s. Immedi-
ately following its passage, the Medicare program began allocating 
millions of federal dollars into the American health care system, re-
sulting in the health care system’s rapid growth as a sizeable portion 
of the national gross domestic product (“GDP”).105 Since 1960, 
“health spending [in the United States] has grown nearly five times 
as much as GDP . . . [yet the United States does] not achieve longer 
life or overall better health statistics than other industrialized coun-
tries with modern health care systems.”106 However, this increase in 
                                                                                                             
 104 Greaney, supra note 10, at 4. 
 105 Barry R. Furrow, Cost Control and the Affordable Care Act: CRAMPing* 
Our Health Care Appetite, 13 NEV. L.J. 822, 823 (2013) (“Medicare was imple-
mented in 1966; as a result, the federal government immediately began to pour 
millions of federal dollars into health care expenditures, which have rapidly 
grown to ever-higher percentages of our gross domestic product . . . .”). See also 
John Lechleiter, To Bend The Cost Curve Downward, Stop Focusing On Minor 
Cost Cuts, FORBES (Aug. 15, 2014, 8:00 AM), http://www.forbes.com/sites/
johnlechleiter/2014/08/15/to-bend-the-healthcare-cost-curve-downward-stop-fo-
cusing-on-minor-cost-cuts/print/ (“Health spending is by far the biggest single 
factor driving growth in the federal budget—fueled, in large part, by the aging of 
the Baby Boom generation, as 10,000 Americans turn 65 every day for another 
16 years.”). 
 106 Furrow, supra note 105, at 823 (“Yet for all this spending, we do not 
achieve longer life or overall better health statistics than other industrialized coun-
tries with modern health care systems.”). 
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spending has decreased slightly since the 2008 recession,107 creating 
uncertainty as to the underlying cause of this reduction.108 
The concept of “bending the cost curve” developed against this 
backdrop, focusing policymakers’ and academics’ analysis around 
the question: “Does this health reform proposal bend the cost 
curve?”109 This question simply translates into whether a proposed 
                                                                                                             
 107 Furrow, supra note 105, at 824 (“The recession of 2008 has reduced this 
differential [between health care costs and general inflation]; health spending and 
GDP grew at similar rates in 2010, with health spending as a share of GDP steady 
at 17.9%. National health expenditures growth has ranged from as high as 11.0% 
in 1990 to 3.9% in 2010.”). See also Sophie Novack, The Health Cost Curve Is 
Bending. Is Obamacare to Blame?, NAT’L J. (Jan. 2, 2014), http://www.national
journal.com/health-care/2014/01/02/health-cost-curve-is-bending-is-obamacare-
blame (“Federal actuaries estimate that real spending on health care increased 
only 0.8 percent per person in 2012, slightly less than real gross domestic product 
per capita. Comparatively, since 1960, spending has increased an average of 2.3 
percentage points more than GDP growth.”); Ezra Klein, The cost curve is bend-
ing. Does Obamacare deserve the credit?, THE WASH. POST: WONKBLOG (May 
31, 2013), https://www.washingtonpost.com/news/wonk/wp/2013/05/31/the-
cost-curve-is-bending-does-obamacare-deserve-the-credit/ (“National health 
spending grew by 3.9 percent each year from 2009 to 2011, the lowest rate of 
growth since the federal government began keeping such statistics in 1960 . . . .” 
(internal quotation marks omitted)). See generally Charles Roehrig, What Is Be-
hind The Post-Recession Bend In The Health Care Cost Curve?, HEALTH AFF. 
BLOG (Mar. 23, 2015), http://healthaffairs.org/blog/2015/03/23/what-is-behind-
the-post-recession-bend-in-the-health-care-cost-curve/print/ (Exhibit 2 titled 
“Shares Of NHE [National Health Expenditures]: Middle Of Post-Recession Pe-
riod (2011)” exhibiting the break down in health care spending for 2011). 
 108 See Furrow, supra note 105, at 824 (“Slowing in health care spending may 
be due to several factors.”); Klein, supra note 107 (“The curve is bending, but we 
don’t really know why, and we don’t know if it’ll stay bent.”); Novack, supra note 
107 (“The recent slowdown is promising, but analysts remain split over what ac-
counts for the change—and, consequently, how long it will be sustained. The 
more pessimistic view is that the lower cost growth is a result of the recession and 
will inflate again as the economy recovers. The optimistic explanation is that 
measures to control costs might finally be working—including related provisions 
in the Affordable Care Act.”); Roehrig, supra note 107 (“I now turn to . . . the 
record low growth in NHE that began in 2009 . . . and continued through 
2013 . . . .There has been extensive discussion about whether these low rates are 
the result of temporary cyclical factors, such as the recession, or more permanent 
structural factors.”). 
 109 Chris Frates, CBO: Bend the cost curve, what does that even mean?, 
POLITICO.COM: LIVE PULSE (Oct. 30, 2009), http://www.politico.com/livepulse/
1009/CBO_Bend_the_cost_curve_what_does_that_even_mean.html (“It’s a 
question that is endlessly asked in Washington, ‘Does this health reform proposal 
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health reform will lower health care costs over time.110 While this 
has become a catch-phrase to describe what politicians and policy-
makers hope the reforms under the ACA—such as the ACO model 
of care—will do, some find it difficult to project whether a proposed 
reform will actually “bend” health care costs.111 Regardless of the 
measurability of the “bend” of the cost curve, the success of reforms 
like the ACO model of care are critically necessary—their success 
could dictate whether “coverage will be affordable and the federal 
budget will be close to balanced” or whether “it will be very difficult 
for the federal government . . . to keep the spending commitments 
made in the health reform act.”112 
1. RE-VALUING VALUE-BASED PAYMENTS TO “BEND THE COST 
CURVE” 
“Bending the cost curve” has become synonymous with restrain-
ing costs under the “Triple Aim” and is a major metric in the debate 
over the effectiveness of ACOs in containing health care costs. The 
key strategy to accomplishing this “bend”—which drives the mis-
sion of ACOs—is the transition from a fee-for-service payment sys-
tem to a value-based payment system.113 Under the fee-for-service 
                                                                                                             
bend the cost curve?’ Really, it’s just a highfalutin way of asking, ‘Does this lower 
costs over time?’”); Timothy C. Gutwald, Bending the Health Care Cost Curve: 
Incentivizing Quality and Efficiency, 90 MICH. B.J. 20, 20 (2011) (“If health care 
spending trends continued, the Congressional Budget Office estimated that by 
2025, one quarter of our gross domestic product would be devoted to health care. 
Armed with this data, politicians and policymakers began to talk about ‘bending 
the cost curve.’”). 
 110 Frates, supra note 109. 
 111 Id. (quoting Doug Elmendorf, Director of the Congressional Budget Office 
as he expounded on how “it’s hard to know whether a proposal . . . will continue 
[to lower costs] . . . indefinitely or, to put it another way, that the curve will stay 
bent.”). Elmendorf concludes that a more productive analysis is considering 
“whether proposals would ‘lower’ or ‘raise’ the curve . . . than to discuss those 
proposals’ effects on the shape of the curve.” See id. 
 112 David Cutler, How Health Care Reform Must Bend The Cost Curve, 29 
HEALTH AFF. 1131, 1131 (2010) (“[W]hether reform is successful over the long 
haul will be determined almost exclusively by its impact on health care spending 
beyond the first decade.”). 
 113 Corbett, supra note 25, at 149 (“Various provisions . . . [of the ACA] are 
designed to ‘shift the payment system from traditional fee-for-service (FFS) to 
budgeted . . . or value-based (e.g., pay-for-performance) payment models.”). See 
also Furrow, supra note 105, at 861 (“As U.S. healthcare begins to move from an 
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payment system, physicians and health care providers are paid for 
the quantity of services provided rather than for the quality of the 
services provided.114 The incentives from a fee-for-service payment 
system are straight forward: “[T]he present [fee-for-service] system 
encourages health care providers to offer more and more costly 
treatments, not just those that are effective or cost-effective.”115 This 
“do more to make more”116 payment system results in inefficient, 
ineffective, and unsafe treatment procedures, tests, and diagnoses, 
further contributing to the rise in health care spending.117 
                                                                                                             
activity-based business model that incentivizes utilization of services to a value-
based model that incentivizes population health management across the contin-
uum of care, thousands of healthcare ‘science projects’ are taking place in com-
munities nationwide.”); Novack, supra note 107 (“Provider-payment reform fo-
cuses on moving away from the current fee-for-service model toward more value-
based rewards, with incentives that encourage efficient and quality care, rather 
than quantity.”). 
 114 Greaney, supra note 10, at 15 (“Since its inception, traditional Medicare 
has reimbursed providers using methodologies that reward volume . . . [by pay-
ing] on a fee-for-service basis, i.e. issuing a separate payment for each service 
provided.”). 
 115 Gutwald, supra note 109, at 21. See also Jeff Goldsmith, Accountable Care 
Organizations: The Case For Flexible Partnerships Between Health Plans and 
Providers, 30 HEALTH AFF. 32, 32 (2011) (“As is well known, this approach [fee-
for-service] offers providers powerful financial incentives to increase the volume 
of services they deliver.”); Greaney, supra note 10, at 5 (“Most notably, the 
longstanding reliance on fee-for-service methods of payment has spawned an 
ethos of provider payment that rewards volume and disincentivizes cost-benefit 
tradeoffs.”); id. at 15 (“As a result of fee-for-service payment, physicians have 
strong incentives to increase the volume of services provided in hospitals . . . .”). 
However, “[t]his is not to say that physicians or hospitals try to keep people sick 
or knowingly provide unnecessary care . . . .However, the fee-for-service system 
offers little motivation to improve quality or efficiency or provide services that 
have a low profit margin.” See Gutwald, supra note 109, at 21. 
 116 Goldsmith, supra note 115, at 35. 
 117 DeMuro, supra note 11, at 16 (“The unsustainable rate of increase in 
healthcare spending in the United States is thought by many to stem from our 
historic reliance on fee-for-service as the method of paying for the delivery of 
healthcare.”); Furrow, supra note 105, at 829 (“The modes of reimbursement—
fee-for-service payment to physicians and ‘usual, customary, and reasonable’ 
charges—created a national crisis by 1970.”); Jessica L. Mantel, Accountable 
Care Organizations: Can We Have Our Cake and Eat it Too?, 42 SETON HALL L. 
REV. 1393, 1396 (2012) (“Unfortunately, the health care system as currently or-
ganized has limited capacity to reduce waste or improve the management of 
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To counter the lucrative fee-for-service payment system, the 
ACA shifts the payment method to a value-based purchasing sys-
tem, also known as “pay-for-performance.”118 This system posits us-
ing “outcome measures tied to pay to begin the process of moving 
from payment per procedure to true outcome-driven health care.”119 
By “linking existing measures of inpatient quality to payment, and 
expanding performance-based measurement and payment systems,” 
the value-based payment system aims to bring the focus of care on 
quality rather than on quantity.120 Because many of the quality 
measures used under the volume-based purchasing system are be-
lieved to lower health care costs,121 this payment method incentiv-
izes “efficient and quality care, rather than quantity”122 with the in-
tention of “bending the cost curve.” The value-based purchasing 
payment method hopes to balance the “Triple Aim” by reducing 
costs while increasing quality and efficiency of care. 
B. Are ACOs Under Medicare Successfully Bending the Cost 
Curve? 
At a high level overview of spending in the American health care 
system, costs have gone down annually since 2008. Between the 
2005–2007 period and the 2009–2013 period, the growth rate in na-
tional health spending dropped 2.6 percentage points from 6.5% to 
3.9%.123 This is the “lowest rate of growth since the federal govern-
ment began keeping such statistics in 1960,” and could mean $770 
billion in savings for the government if maintained over the next 
decade.124 
The Medicare program similarly experienced a drop in spending 
and experienced a fall in the growth rate in spending on health care 
                                                                                                             
chronic care patients. In particular, incentives inherent in our fee-for-service pay-
ment system result in a fragmented delivery system and promote both a higher 
volume and intensity of care.”). 
 118 See supra note 113. 
 119 Furrow, supra note 105, at 860. 
 120 See Cutler, supra note 112, at 1134. 
 121 See id. (“Many of the quality measures being considered are associated 
with lower costs—for example, improvements in patient safety.”). 
 122 See Novack, supra note 107. 
 123 Roehrig, supra note 107. 
 124 Klein, supra note 107. 
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services (excluding dental services) in comparison to overall spend-
ing.125 This reduction occurred while Medicare beneficiary enroll-
ment grew nearly a percentage point faster during the 2009–2013 
period than the 2005–2007 period.126 While the reason for these sav-
ings remains somewhat unexplained, two major theories have 
arisen: 1) These savings are the short-lived effects of the 2008 re-
cession and will likely end as the economy continues to regain mo-
mentum, or 2) the effects of the major reforms under the ACA are 
working.127 
This then begs the question: are ACOs actually contributing to 
“bending the cost curve?” The official position of the CMS is “yes,” 
and that the “bend” is occurring across the various ACO programs 
offered.128 Based on yearly performance results, “Medicare [ACOs] 
. . . continue to improve the quality of care for Medicare beneficiar-
ies, while generating financial savings.”129 Quantitatively, this 
meant that “the 20 . . . Pioneer ACO Model[s] and [the] 333 . . . 
[MSSP] ACOs generated more than $411 million in total savings in 
2014”130 while generating over $417 million in savings for Medicare 
in 2013.131 Of these savings, 97 of the participating ACOs qualified 
                                                                                                             
 125 Roehrig, supra note 107. 
 126 Id. 
 127 See Klein, supra note 107; Novack, supra note 107. 
 128 See generally Centers for Medicare & Medicaid Services, Medicare ACOs 
continue to succeed in improving care, lowering cost growth, CTRS. MEDICARE & 
MEDICAID SERVS. (Nov. 10, 2014), https://www.cms.gov/Newsroom/MediaRe-
leaseDatabase/Fact-sheets/2014-Fact-sheets-items/2014-11-10.html [hereinafter 
Medicare ACOs Fact Sheet 2014]; Centers for Medicare & Medicaid Services, 
Medicare ACOs Provide Improved Care While Slowing Cost Growth in 2014, 
CTRS. MEDICARE & MEDICAID SERVS. (Aug. 25, 2015), https://www.cms.gov/
Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-08-
25.html [hereinafter Medicare ACOs Fact Sheet 2015]. See also, John Okray, Ac-
countable Care Organizations Start to Pay Dividends, 61 FED. LAW. 14 (2014) 
(showing the findings reported by CMS in their September 2014 announcement 
with regards to participating ACOs). 
 129 Medicare ACOs Fact Sheet 2015, supra note 128. See also Medicare ACOs 
Fact Sheet 2014, supra note 128 (showing that the financial and quality results 
for Performance Year 2 (2013) resulted in similar financial savings and achieving 
quality measures). 
 130 Medicare ACOs Fact Sheet 2015, supra note 128. 
 131 Medicare ACOs Fact Sheet 2014, supra note 128 (“ACOs in the Pioneer 
ACO Model and [MSSP] . . . also generated over $417 million in savings for 
Medicare.”). 
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for shared savings payments totaling $422 million.132 Quality stand-
ards are consistently being met for the majority of ACOs sur-
veyed.133 
While such enormous savings are positive on their face, they 
may be somewhat deceiving as they do not reflect the number of 
ACOs generating savings in a given year—or, alternatively, not gen-
erating savings at all. This may simply be a reflection of savings 
generated by some ACOs, rather than a testament to the program as 
a whole “bending the cost curve.”134 It would seem that a compre-
hensive evaluation would consider both the dollar amount saved by 
the various ACO programs, as well as the number of ACOs actually 
generating savings. Such a holistic analysis can be conducted with 
the detailed information collected on the Pioneer ACO Model since 
its inception.135 During the three years of reported data on partici-
pating Pioneer ACOs, all were able to meet the quality standards set 
for that year.136 “However, the first-year experience for many of the 
Pioneer ACOs illustrates a disconnect between the quality measures 
and cost savings,”137 though this disconnect seems to be lessening 
each year.138 
                                                                                                             
 132 Medicare ACOs Fact Sheet 2015, supra note 128 (“At the same time, 97 
ACOs qualified for shared savings payments of more than $422 million by meet-
ing quality standards and their savings threshold.”). 
 133 See Pioneer ACO Model, supra note 89 (under “Initiative Details,” select 
“Performance Year 1 (2012)”); Pioneer ACO Model, supra note 89 (under “Initi-
ative Details,” select “Performance Year 2 (2013)”); Pioneer ACO Model, supra 
note 89 (under “Initiative Details,” select “Performance Year 3 (2014)”); Pioneer 
ACO Model, supra note 89 (under “Initiative Details,” select “Performance Year 
4 (2015)”). 
 134 See supra note 133. 
 135 See id. 
 136 See id. 
 137 Ken Perez, Emerging Opportunities for ACO Cost Reduction, 
HEALTHCARE FIN. MGMT. 116, 116 (2014). See also supra Table 1. 
 138 See supra Table 1. One explanation for this seeming “lessening effect” is 
that the number of participating Pioneer ACOs has decreased each year since the 
first year of the program (2012). See also Pioneer ACO Model, supra note 89 
(under “Initiative Details,” select “Performance Year 1 (2012)”); Pioneer ACO 
Model, supra note 89 (under “Initiative Details,” select “Performance Year 2 
(2013)”); Pioneer ACO Model, supra note 89 (under “Initiative Details,” select 
“Performance Year 3 (2014)”); Pioneer ACO Model, supra note 89 (under “Initi-
ative Details,” select “Performance Year 4 (2015)”). From this, one may also 
make the conjecture that the remaining Pioneer ACOs in the program are the high-
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Table 1 Number and Percentage of Pioneer ACOs Owing 






Number   
of Pioneer 






ACOs      
Owing 
Losses 
Number      
of Pioneer 
ACOs Owing 
Losses/      
Receiving $0 
in Shared   
Savings 
Percentage   
of Pioneer 
ACOs Owing 








3.13% 19 out 






26.09% 12 out 






15.00% 9 out 






8.33% 6 out 
of 12 (+5) 
50.00% 
Source: Author’s calculation based on data provided at https://inno-
vation.cms.gov/initiatives/Pioneer-ACO-Model/index.html. 
 
Table 1 presents two sets of data relevant to understanding the 
number of Pioneer ACOs generating a loss or zero savings for the 
Medicare program over the four years of available data.139 The sec-
ond and third columns reflect the number and percentage, respec-
tively, of participating Pioneer ACOs which incurred a loss—and 
subsequently owed money—for Medicare.140 The third and fourth 
                                                                                                             
performing ACOs that were able to meet both the quality standards and the cost-
reducing requirements. Id. While not necessarily a novel revelation, it does beg 
the question of whether the Pioneer ACO program is simply “weeding out” the 
ineffective participants, leaving a small pool of effective ACOs to dominate the 
market in the future. Such an inference would bolster the fear of ACOs monopo-
lizing the health care industry. See infra note 163. 
 139 See supra Table 1. See also Pioneer ACO Model, supra note 89 (under 
“Initiative Details,” select “Performance Year 1 (2012)”); Pioneer ACO Model, 
supra note 89 (under “Initiative Details,” select “Performance Year 2 (2013)”); 
Pioneer ACO Model, supra note 89 (under “Initiative Details,” select “Perfor-
mance Year 3 (2014)”); Pioneer ACO Model, supra note 89 (under “Initiative 
Details,” select “Performance Year 4 (2015)”). See generally Pioneer ACO 
Model, supra note 89. 
 140 See supra note 139. 
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columns reflect the number and percentage, respectively, of partici-
pating Pioneer ACOs which either incurred a loss or received no 
shared savings but did not owe money to Medicare.141 In essence, 
all participating Pioneer ACOs are meeting the quality standards; 
however, the same is not true for the savings thresholds set for each 
participating ACO.142 
Although the intention “is that by meeting the thirty-three qual-
ity-performance standards, the needed cost savings will naturally 
follow,”143 Table 1 suggests that cost savings do not always follow 
simply from meeting the quality standards.144 However, as Table 1 
also reflects, the gap between quality standards and cost savings has 
progressively decreased each year since the beginning of the pro-
gram.145 Whether this is due to the fact that fewer ACOs are partic-
ipating in the Pioneer Model program, or whether it is due to actual 
improvements in strategies for cost savings, is beyond the scope of 
this Comment. However, such a discrepancy should be clarified in 
the CMS analysis and presentation of data as it may be creating a 
false perception of success in the Pioneer ACO program.146 
                                                                                                             
 141 See id. The reason some Pioneer ACOs owe no money to Medicare but do 
not receive a portion of shared savings is due to their contractual relationship with 
CMS—the “one-sided contract.” See Part I, section C, subsections 1–2. 
 142 See supra Table 1. See also Pioneer ACO Model, supra note 89 (under 
“Initiative Details,” select “Performance Year 1 (2012)”); Pioneer ACO Model, 
supra note 89 (under “Initiative Details,” select “Performance Year 2 (2013)”); 
Pioneer ACO Model, supra note 89 (under “Initiative Details,” select “Perfor-
mance Year 3 (2014)”); Pioneer ACO Model, supra note 89 (under “Initiative 
Details,” select “Performance Year 4 (2015)”). 
 143 Perez, supra note 137, at 116. 
 144 See supra note 139. 
 145 See id. 
 146 See generally Perez, supra note 137, at 116; Pioneer ACO Model, supra 
note 89 (under “Initiative Details,” select “Performance Year 1 (2012)”); Pioneer 
ACO Model, supra note 89 (under “Initiative Details,” select “Performance Year 
2 (2013)”); Pioneer ACO Model, supra note 89 (under “Initiative Details,” select 
“Performance Year 3 (2014)”); Pioneer ACO Model, supra note 89 (under “Initi-
ative Details,” select “Performance Year 4 (2015)”).; Medicare ACOs Fact Sheet 
2015, supra note 128; Medicare ACOs Fact Sheet 2014, supra note 128; Pioneer 
ACO Model, supra note 89; supra Table 1. 
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C. Can More Be Done to Bend the Cost Curve? 
While the ACO model has resulted in general savings since its 
inception, some argue that the model focuses on low-impact cost-
saving measures.147 With such mixed opinions about the success—
or failure—of the ACO model, can more be done to effectively 
“bend the cost curve” in a more meaningful way? Several proposals 
have been made in the literature,148 which may be beneficial for the 
CMI and the CMS to review and possibly incorporate. Though the 
list of proposals here is not exhaustive, it presents a snapshot of pro-
posals introduced by both conservative and liberal advocates that 
could potentially result in savings to further “bend the cost curve.” 
1. IDENTIFYING EXTERNAL INFLUENCES ON THE FINANCIAL 
BENCHMARKS 
One major set of reforms calls for refining the financial bench-
marks ACOs must meet.149 While much of the current literature fo-
cuses on reforming the payment method for health services pro-
vided,150 it would be beneficial to consider external influences that 
may hinder effective cost savings. One measure is to recognize and 
                                                                                                             
 147 See Lechleiter, supra note 105 (arguing that “[i]f we simply take projec-
tions of future costs as a given and settle for trimming costs off that trend line, we 
will lose opportunities to truly bend the cost curve, and more importantly, to 
achieve levels of health and well-being that are unattainable with current technol-
ogy and financial resources.”). 
 148 See, e.g., infra notes 150, 162–63, 166, 170. 
 149 See generally Ezekiel Emanuel et al., A Systemic Approach to Containing 
Health Care Spending, 367 NEW ENG. J. MED. 949 (2012); Hamilton Moses III et 
al., The Anatomy of Health Care in the United States, 310 J. AM. MED. ASS’N 
1947 (2013); Lechleiter, supra note 105; James J. Mongan et al., Options for 
Slowing the Growth of Health Care Costs, 358 NEW ENG. J. MED. 1509 (2008); 
Wehrwein, supra note 95. 
 150 See, e.g., supra note 149. See also Muhlestein, supra note 25 (“Much of 
the policy conversation around accountable care has focused on payment models. 
While it is certain that payment models do incent[ivize] behavior, adopting a pay-
ment model does not guarantee that a provider will be able to transform the prac-
tice of care in a way that improves outcomes and lowers costs . . . . A myopic 
policy focus on payment ignores the core objective of accountable care . . . .”). 
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adjust for regional variations in costs and prices, which have nega-
tively impacted some participating ACOs.151 Such a proposal calls 
for the financial benchmarks to take into account the regional vari-
ances in the area–wage index, one factor used to calculate Medicare 
payments.152 
Similarly, it is critical to recognize that the ACO model’s ability 
to “bend the cost curve” is limited by the continuing rise in the price 
of health care goods and services in the United States.153 Although 
the ACO model works to reduce costs for the patient and Medicare, 
this model cannot control for the general price of goods and services 
used in the provision of care. The reality of health care in the United 
States is that some costs can only be controlled when external fac-
tors—such as the general price of health care goods and services—
are controlled.154 Recognizing that a portion of costs generated by 
                                                                                                             
 151 See Wehrwein, supra note 95 (Some Pioneer ACOs “stood to get penalized 
even though [they] launched . . . management programs, reined in hospital read-
missions, and reduced its high rate[s]. The Pioneer financial benchmarks were the 
problem . . . .” ). See also Emanuel et al., supra note 149, at 951 (“Prices for the 
same services vary substantially within the same geographic area.”). 
 152 Wehrwein, supra note 95 (“First, the benchmarks haven’t taken into ac-
count regional variances in the area-wage index, one of the factors used to calcu-
late Medicare inpatient hospital payment.”). The area-wage index is a standard-
ized amount adjusted “for area differences in hospital wage levels by a factor (es-
tablished by the Secretary) reflecting the relative hospital wage level in the geo-
graphic area of the hospital compared to the national average hospital wage level.” 
Centers for Medicare & Medicaid Services, Wage Index, CTRS. MEDICARE & 
MEDICAID SERVS. (Aug. 4, 2014), https://www.cms.gov/Medicare/Medicare-Fee-
for-Service-Payment/AcuteInpatientPPS/wageindex.html (internal quotation 
marks removed). 
 153 See Moses III et al., supra note 149, at 1949 (“Since 2000, increase in price 
has continued but has moderated from historical norms . . . .”). While many have 
argued that the greatest impact on spending in the American health care system 
has resulted from an ever aging population, along with a higher demand for health 
services, data seems to contradict this belief. See id. (“[D]ata contradict[s] [the] 
commonly held belief that aging of the population and increased demand for ser-
vices have driven spending historically.”). See also id. at 1951 (Figure 5 provides 
a graphical representation of how medical price growth, while modestly decreas-
ing over time, still remains the greatest portion of health care spending in the 
United States). 
 154 While this may be an unfavorable—or politically unfeasible—recommen-
dation within the American philosophical framework of individualism and capi-
talism, the data continues to indicate that it is one that must be recognized if ef-
fective reforms are to be made. See id. at 1949 (“Between 2000 and 2011, increase 
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ACOs does not necessarily come from excessive or ineffective care, 
but rather from the general price of health goods and services in 
America, could help shape meaningful policies that truly “bend the 
cost curve” and improve the impact of ACOs on the health care sys-
tem.155 
2. TRANSPARENCY AND PATIENT CHOICE 
Another major line of proposals aims to improve transparency 
and patient choice within the ACO program. As the price of care 
within the American health system continues to consume health 
spending,156 one proposal aims to use transparency as a price control 
strategy.157 Typically, “consumers almost never receive price infor-
mation before treatment,”158 leaving them powerless to make in-
formed decisions about their care.159 This results in price variations 
within a geographical area and between patients receiving the same 
plan of care.160 By requiring health care providers, such as ACOs, 
to make “available information about the cost and quality of health 
                                                                                                             
in price (particularly of drugs, medical devices, and hospital care), not intensity 
of service or demographic change, produced most of the increase in health’s share 
of GDP.”). See also supra note 152. 
 155 See supra note 153. See also Barry G. Saver et al., Care that Matters: 
Quality Measurement and Health Care, 12 PUB. LIBR. MED. 1, 6 (2015) (“[T]here 
should be acknowledgement that improved health is often the result of actions by 
multiple parties at multiple levels, not individual providers. In many cases, patient 
action (or inaction) is critical and individual providers have limited influence.”). 
 156 See Moses III et al., supra note 149, at 1949. 
 157 See Emanuel et al., supra note 149, at 951–52. But see Mongan et al., supra 
note 149, at 1511–12 (“Although the impact of this approach is unknown, we be-
lieve that cost savings are likely to be limited . . . .”). Transparency is defined as 
“making available information about the cost and quality of health care services 
so that patients can become informed consumers.” See id. at 1511. 
 158 Emanuel et al., supra note 149, at 951. One reason for this secrecy is be-
cause of anticompetitive clauses, such as “gag clauses,” that providers incorporate 
in contracts with insurers to “prohibit insurers from releasing price information to 
their members.” See id. at 952. 
 159 See id. at 951. 
 160 See id. This variation in price among geographical areas represents a 
greater market break down best explained by the Lemon Theory and asymmetrical 
information between the seller—the health care provider—and the buyer—the pa-
tient. See generally George A. Akerlof, The Market for “Lemons”: Quality Un-
certainty and the Market Mechanism, 84 Q.J. ECON. 488 (1970). 
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care services” provided,161 patients are better able to evaluate where 
to receive care from.162 This in turn “may lead high-cost providers 
to lower prices” in order to remain competitive within the market.163 
In line with strengthening patient choice, some have proposed 
transitioning from a system of attribution164 to a model of self-en-
rollment in which the beneficiary chooses which ACO to associate 
with.165 By giving the beneficiary the choice, the beneficiary is then 
able to clearly decide which ACO he or she prefers. Rather than 
leaving an ACO “[un]able to identify the patients for whom [it is] 
responsible [for] until after the contract year ends,”166 this model 
ensures that the ACO is clear as to who falls within its assigned pop-
ulation.167 One concern with giving the choice to the beneficiary is 
                                                                                                             
 161 Mongan et al., supra note 149, at 1511. 
 162 See Emanuel et al., supra note 149, at 951 (“Price transparency would al-
low consumers to plan ahead and choose lower-cost providers . . . .”); Mongan et 
al., supra note 149, at 1511. 
 163 See Emanuel et al., supra note 149, at 951. One concern associated with 
the price transparency is the potential for collusion; however, “this risk could be 
addressed through aggressive enforcement of antitrust laws.” See id. The Depart-
ment of Justice and the Federal Trade Commission released a joint statement re-
garding ACOs and antitrust law and enforcement. See Greaney, supra note 10, at 
22–27. 
 164 Under the current system, ACOs are informed by CMS of tentative assign-
ments on a quarterly basis and receive final assignments at the end of each per-
formance year based on data from the previous year. See Valerie A. Lewis et al., 
Attributing Patients To Accountable Care Organizations: Performance Year Ap-
proach Aligns Stakeholders’ Interests, 32 HEALTH AFF. 587, 588–89 (2013) (de-
scribing Medicare’s “hybrid approach” to attribution, which includes quarterly 
prospective assignments and a final year-end assignment); Nicholas Hodges, Ac-
countable Care Organizations: Realigning the Incentive Problems in the U.S. 
Health Care System, 26 U. FLA. J. L. & PUB. POL’Y 99, 114, 114 n.99 (2015) 
(“Note that the literature often uses the word ‘attribution’ to mean the process of 
assigning beneficiaries to an ACO.”). 
 165 See Paul B. Ginsburg & Alice M. Rivlin, Challenges for Medicare at 50, 
373 NEW ENG. J. MED. 1993, 1995 (2015) (“Shifting from an attribution model to 
an enrollment model—in which beneficiaries choose to participate in an ACO and 
have incentives to do so . . . —is the most effective way of engaging beneficiar-
ies.”). But see generally Valerie A. Lewis et al., supra note 164, at 588 (discussing 
research findings on two alternative methods of attribution to the current method 
through Medicare: “prospective attribution” and “performance year attribution”). 
 166 Ginsburg & Rivlin, supra note 165, at 1994–95. 
 167 See supra note 165. This proposal may not be as effective in areas where 
only one ACO is available to the beneficiary. However, on a global scale this 
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the potential for fraud or coercion in attempting to attract a benefi-
ciary to a certain ACO; however, much of this behavior would likely 
be controlled under current fraud and abuse laws.168 
As a result of improved price transparency and patient choice in 
ACO provider, beneficiaries are empowered to take control of their 
care. However, the effectiveness of both these proposals requires 
that patients be more informed consumers. One proposal is to im-
prove the health literacy of participants in the American health care 
system.169 Health literacy is defined as “the degree to which a person 
                                                                                                             
proposal will eliminate some of the confusion ACOs typically face regarding their 
assigned population and will allow ACOs to better track costs. See Ginsburg & 
Rivlin, supra note 165, at 1994–95. 
 168 See generally 42 U.S.C. § 1320a–7b (2012); 42 U.S.C. § 1395nn (2012). 
But see Benjamin Holland Able, The Stark Physician Self-Referral Law and Ac-
countable Care Organizations: Collision Course or Opportunity to Reconcile 
Federal Anti-Abuse and Cost-Saving Legislation?, 26 J.L. & HEALTH 315 (2013); 
BARRY D. ALEXANDER ET AL., THE FUNDAMENTALS OF HEALTH LAW 180, 201 
(6th ed. 2014) (“On November 2, 2011, the OIG [Office of Inspector General], in 
conjunction with CMS, issued an interim final rule with comment period estab-
lishing waivers of the Anti-Kickback Statute [and Stark Law] . . . to particular 
arrangements involving ACOs under the Medicare shared savings program. While 
not technically a safe harbor, the interim final rule establishes five waivers of ap-
plication of the Stark law, the Anti-Kickback Statute, and the Civil Monetary Pen-
alty provisions related to gainsharing and beneficiary inducements if certain con-
ditions are met. According to the interim final rule, an arrangement need only fit 
one wavier to be protected.”); Greaney, supra note 10, at 14; Wasif Ali Khan, 
Accountable Care Organizations: A Response to Critical Voices, 14 DEPAUL J. 
HEALTH CARE L. 309, 326–27, 332–38 (2012); Pasquale, supra note 44, at 1376–
77. 
 169 See generally Brietta Clark, Using Law to Fight a Silent Epidemic: The 
Role of Health Literacy in Health Care Access, Quality, & Cost, 20 ANNALS 
HEALTH L. 253 (2011) (providing a thorough description of the health literacy 
strategy and its ability to induce cost savings in the American health care system). 
A number of governmental agencies have researched and pursued health literacy 
as a strategy for health promotion in the United States. See, e.g., COMM. ON 
HEALTH LITERACY, INST. OF MED., HEALTH LITERACY: A PRESCRIPTION TO END 
CONFUSION (Lynn Nielsen-Bohlman et al. eds., 2004); Off. Disease Prevention & 
Health Promotion, Health Literacy and Communication, HEALTH.GOV (Jan. 14, 
2016), http://health.gov/communication/ [hereinafter Health Literacy Website]. 
This has manifested in health literacy being incorporated as a major objective of 
Healthy People 2020, a “science-based, 10-year national [initiative] . . . for im-
proving the health of all Americans.” See Off. Disease Prevention & Health Pro-
motion, About Healthy People, HEALTHYPEOPLE.GOV (Jan. 13, 2016), http://
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has the capacity to obtain, communicate, process, and understand 
basic health information and services in order to make appropriate 
health decisions.”170 Promoting health literacy among patients 
would likely result in a more informed consumer population while 
producing “significant cost savings for providers, insurers, and the 
government.”171 By “empowering patients with better information 
and decision-making skills,”172 patients are able to choose the ACO 
and range of care most suitable to their needs, preferences, and fi-
nancial ability. 
III. PERSPECTIVE #2: QUALITY OF CARE AND THE METHODOLOGY 
OF GRADING ACOS 
The second perspective considers the quality performance 
measures ACOs must meet in conjunction with the cost-saving 
measures in order to receive a portion of the shared savings. Under-
lying these measures is what “high-quality care” means: “It is care 
that assists healthy people to stay healthy, cures acute illnesses, and 
allows chronically ill people to live as long and fulfilling a life as 
possible.”173 This section will begin with a description of the quality 
                                                                                                             
www.healthypeople.gov/2020/About-Healthy-People [hereinafter Healthy Peo-
ple Website]. See also Off. Disease Prevention & Health Promotion, Health Com-
munication and Health Information Technology, HEALTHYPEOPLE.GOV (Jan. 13, 
2016), http://www.healthypeople.gov/2020/topics-objectives/topic/health-com
munication-and-health-information-technology/objectives (Health literacy falls 
under the major topic of “Health Communication and Health Information Tech-
nology” and is coded as “HC/HIT-1 Improve the health literacy of the popula-
tion”). 
 170 Health Literacy Website, supra note 169 (select “About” on left column). 
See also Clark, supra note 169, at 258–59 (providing various definitions for 
“health literacy”). 
 171 Clark, supra note 169, at 272. 
 172 Id. at 274. Clark proposes several ways to improve health literacy among 
Americans, including providing various forms and comprehension levels of infor-
mation, patient coaching and patient-centered materials, and encouraging patient 
questions and dialogue. See Clark, supra note 169, at 278–83. 
 173 THOMAS S. BODENHEIMER & KEVIN GRUMBACH, UNDERSTANDING 
HEALTH POLICY: A CLINICAL APPROACH, 111, 111 (5th ed. 2009). Bodenheimer 
and Grumbach build further on this definition by explaining the various compo-
nents of “high-quality care,” including “access to care,” “adequate scientific 
knowledge,” “competent health care providers,” “separation of financial and clin-
ical decisions,” and “organization of health care institutions to maximize quality.” 
See generally id. at 111–16. 
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performance measures used by the CMS to evaluate ACOs. It will 
then consider whether these quality measures are effective in pro-
ducing “quality care” for beneficiaries. It will end with a suggested 
general reengineering of the quality measures used to evaluate 
ACOs. 
A. Grading the ACOs: The Four Domains of Review 
In an effort to improve the quality of care provided by ACOs, 
the CMS incorporated quality performance measures to the evalua-
tion scheme of ACOs.174 ACOs must meet thirty-three quality per-
formance measures set for a given year in order to share in any sav-
ings generated during that year.175 Based on nationally recognized 
standards,176 these thirty-three quality measures span four domains 
that chart the post-ACA path to “quality care.”177 The four domains 
include: 1) patient/caregiver experience; 2) care coordination/pa-
tient safety; 3) preventive health; and 4) at-risk population, includ-
ing diabetes, hypertension, ischemic vascular disease, heart failure, 
and coronary artery disease.178 
ACOs are required to thoroughly report on all thirty-three qual-
ity measures at each reporting period during a performance year.179 
                                                                                                             
 174 See generally Guide to Quality Performance, supra note 85. 
 175 See id. at 1. These thirty-three quality measures were developed by a con-
sortium of non-profit health organizations and institutions known as “measure 
stewards” and include organizations like the Agency for Healthcare Research and 
Quality and the National Committee on Quality Assurance. See CTRS. MEDICARE 
& MEDICAID SERVS., ACCOUNTABLE CARE ORGANIZATIONS 2015 PROGRAM 
ANALYSIS QUALITY PERFORMANCE STANDARDS NARRATIVE MEASURE 
SPECIFICATIONS 1, 1–6 (2015) (providing a brief introduction on ACOs and the 
quality measures, as well as detailed information regarding the measure and meas-
ure steward associated with the measure). 
 176 See generally PPACA, tit. III, subtit. A, pt. II, secs. 3013–14, 124 Stat. at 
381–89; 42 C.F.R. § 425.500–.502 (2014); Barry G. Saver et al., supra note 155, 
at 3 (“[T]hese measures are typically derived from the Healthcare Effectiveness 
Data and Information Set (HEDIS), whose sponsor states they ‘were designed to 
assess measures for comparison among health care systems, not measures for 
quality improvement.’” (bold in original)). 
 177 See Guide to Quality Performance, supra note 85, at 1. 
 178 See id. 
 179 See id. A “performance year” consists of a twelve-month period, beginning 
on January 1 of each year during the agreement period. See id. at 2. A “reporting 
period” also consists of a twelve-month period, beginning on January 1 of each 
year during the agreement period. See Centers for Medicare & Medicaid Services, 
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Reporting and data collection is done through a variety of methods, 
including web interface, patient surveys, claims data, and data from 
electronic health records.180 This data is then evaluated and used to 
score ACOs across the measures and domains set for a performance 
year.181 At the onset of the ACO program, payment was based on an 
ACO completely and accurately reporting on all thirty-three quality 
measures.182 However, the CMS is transitioning away from this pay-
ment model to a “pay for performance” model183 in which ACOs 
must meet performance benchmarks—rather than reporting bench-
marks—to share in any savings realized.184 
The CMS sets a “Minimal Attainment Level” for each measure, 
which is the minimum threshold an ACO must meet to earn points 
in a given domain.185 The minimum attainment level was initially 
set at 30% or the 30th percentile under the pay-for-performance 
model, meaning the ACO being evaluated would need to perform 
                                                                                                             
Guide to Quality Measurement for Accountable Care Organizations Starting in 
2012: Agreement Period, Performance Year, and Reporting Period, CTRS. 
MEDICARE & MEDICAID SERVS. 1, 3 (“All quality measures will have a [twelve]-
month, calendar year reporting period, regardless of ACO start date.”). See also 
id. at 2 (providing a breakdown of the performance year and corresponding re-
porting period in table form). 
 180 See Guide to Quality Performance, supra note 85, at 1. 
 181 See id. at 2, 3. 
 182 See id. at 2. 
 183 The “pay-for-performance” model—using “outcome measures tied to 
pay . . . [used to move] from payment per procedure to true outcome-driven health 
care”—is a major cost-saving and quality improving measure implemented 
through various programs under the ACA. See generally Furrow, supra note 105, 
at 860–62. 
 184 See Guide to Quality Performance, supra note 85, at 2. In Performance 
Year 1, ACOs were able to meet quality performance measures by reporting on 
all thirty-three measures. See id. In subsequent performance years, ACOs must 
meet performance benchmarks for a greater share of the measures until the pro-
gram completely transitions to all measures being evaluated on performance as 
opposed to reporting. See id. 
 185 See Guide to Quality Performance, supra note 85, at 2–3; Hodges, supra 
note 164, at 118; Centers for Medicare & Medicaid Services, Medicare Shared 
Savings Program Quality Measure Benchmarks for the 2014 Reporting Year, 
CTRS. MEDICARE & MEDICAID SERVS. 1, 4 (Feb. 2015), https://www.cms.gov
/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Down-
loads/MSSP-QM-Benchmarks-2015.pdf [hereinafter Quality Measure Bench-
marks 2014]. 
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better than the bottom 30% of providers evaluated.186 So long as the 
minimum attainment level is met or passed on at least one measure 
for each of the four domains, the ACO will earn points and likely be 
eligible for a share of the savings generated.187 However, if the ACO 
fails to meet the minimum attainment level, it will receive no points 
for the given measure.188 Failure to meet the minimum attainment 
level on at least 70% of the measures in each domain may result in 
warnings or termination, as well as the ACO no longer qualifying 
for shared savings.189 
Each measure is scored on a scale from 0 to 2, except for one 
measure—the Electronic Health Records measure—which is meas-
ured on a scale from 0 to 4.190 Points earned on this “sliding scale” 
are based on an ACO’s actual level of performance on a given meas-
ure.191 Thus, the better an ACO performs on a given measure, the 
more points an ACO is able to earn.192 The total points earned for 
each measure within a given domain are then summed and divided 
                                                                                                             
 186 See Guide to Quality Performance, supra note 85, at 2; Hodges, supra note 
164, at 118 (“CMS has set a minimum attainment level at the 30th percentile of 
each performance benchmark.”). However, this percentage is set to increase over 
time in order to drive quality up. See id. (“CMS intends to gradually raise the 
minimum attainment level over time in order to drive quality improvements 
amongst ACOs.”). 
 187 See Guide to Quality Performance, supra note 85, at 2–3. However, this 
requires that the ACO meet the cost saving criteria as well. See id. at 3. 
 188 See Guide to Quality Performance, supra note 85, at 2. 
 189 See id. at 4. 
 190 See Guide to Quality Performance, supra note 85, at 3. The electronic 
health records measure is weighted more heavily than the other measures in order 
to promote the transition and use of electronic health records among ACOs. See 
id. at 3; Quality Measure Benchmarks 2014, supra note 185, at 4 (“The [Elec-
tronic Health Records] measure is double weighted and worth up to 4 points to 
provide incentive for greater levels of [Electronic Health Records] adoption.”). 
 191 See Guide to Quality Performance, supra note 85, at 3. It is important to 
note that the thirty-three quality measures will be scored as twenty-three measures 
as a result of composite measures, which combine several measures such that the 
overall score is on an “all or nothing basis”—meaning each individual measure in 
a composite measure must be met in order to earn the total points for the compo-
site measure. See id. at 2; Quality Measure Benchmarks 2014, supra note 185, at 
1. 
 192 See Guide to Quality Performance, supra note 85, at 3. For four of the 
quality measures, a reverse sliding scale is used such that a lower score signifies 
better performance and thus results in a higher score. See Quality Measure Bench-
marks 2014, supra note 185, at 4. 
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by the total possible points in the domain, resulting in a percentage 
score for each domain.193 A final overall quality score for the ACO 
is calculated by averaging the percentage score for each of the four 
domains, which is then used to determine the amount of shared sav-
ings the ACO is entitled to.194 
B. A+ or F? Reengineering the Quality Measures to Achieve 
“Quality Care” 
A brief review of the thirty-three measures and four domains re-
veal two major concerns, both of which may be resolved with one 
global strategy. First, as noted earlier, a disconnect exists between 
ACOs meeting the quality measures required of them and the sub-
sequent cost savings that are supposed to be generated.195 This could 
mean that the quality measures are not an effective cost-saving 
tool.196 Second, the measures themselves appear disassociated and 
myopic, seemingly lacking any general direction towards more ho-
listic, long-term improvements in health in the United States.197 
While the current measures are valuable in addressing major health 
concerns in the United States,198 an improved framework of “high-
quality care” is needed, one aimed at improving the long-term health 
status for the patient population the ACO serves rather than imple-
menting temporary fixes.199 
                                                                                                             
 193 See Guide to Quality Performance, supra note 85, at 3; Quality Measure 
Benchmarks 2014, supra note 185, at 5. 
 194 See Quality Measure Benchmarks 2014, supra note 185, at 5 (“[The] final 
overall quality score for each ACO . . . will be used to determine the amount of 
savings it shares or, if applicable, the amount of losses it owes.”); Guide to Quality 
Performance, supra note 85, at 3. Each of the four domains are weighted equally 
at 25%. See id. at 3 (Table 1 reflects the domain weight for each domain); Quality 
Measure Benchmarks 2014, supra note 185, at 4 (Table 1 reflects the domain 
weight for each domain). 
 195 See Part II, section B. 
 196 See id. 
 197 One article suggests that these quality measures “are often based on easily 
measured, intermediate endpoints . . . not on meaningful, patient-centered out-
comes; their use interferes with individualized approaches to clinical complexity 
and may lead to gaming, overtesting, and overtreatment.” See Barry G. Saver et 
al., supra note 155, at 1. 
 198 But see id. at 2 (“Some well-known quality measures do not perform as 
intended, or may even be associated with harm . . . .”). 
 199 See Barry G. Saver et al., supra note 155, at 1–3. 
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Because a disconnect between quality attainment and cost re-
duction currently exists in the ACO model,200 this shift to a long-
term improvements model may, over time, result in more consistent 
reductions in cost. Not only should this model define the goal and 
strategy for achieving sustained, long-term improvements in health, 
but it should also dictate the domains and measures chosen for rating 
ACOs.201 This model would shift the ACOs’ focus from simply 
meeting a random assortment of “quality” measures to aligning their 
quality strategy towards a goal—namely meaningful long-term 
health improvement for their patient population. 
Several frameworks currently exist centered on producing long-
term improvements in the general health status of Americans.202 
Each defines the overlaying goal of the framework and details 
measures used to determine whether the goal of long-term health 
improvement is being met.203 One such framework is “Healthy Peo-
ple 2020,”204 a national program whose mission and measures are 
updated every ten years in response to the shifting needs and current 
status of health in the United States.205 Three other potential frame-
works in the literature may be of value in determining the overall 
mission, framework, and measures to evaluate ACOs. 
One potential framework is a public health-centered frame-
work206 that addresses current challenges in the provision of health 
through “a combination of technological advances, more effective 
clinical and administrative systems, and political commitment to in-
vest in prevention and control” of patient health outcomes.207 Under 
                                                                                                             
 200 See supra Part II, section B and accompanying notes. 
 201 This process of creating quality measures by which to evaluate ACOs 
should be done in a transparent manner—rather than in the bureaucratic, stake-
holder-influenced manner currently used. See Barry G. Saver et al., supra note 
155, at 2, 3 (“Such measures should merit public trust, earn the support of clini-
cians, and promote the empowerment of patients. Their development should be 
open and transparent with careful attention to the best evidence of utility.”); supra 
note 175–76. 
 202 See, e.g., Barry G. Saver et al., supra note 155; Healthy People Website, 
supra note 169; Thomas R. Frieden, The Future of Public Health, 373 NEW ENG. 
J. MED. 1748 (2015). 
 203 See supra note 202. 
 204 Healthy People Website, supra note 169. 
 205 Id. 
 206 See Frieden, supra note 202, at 1749. 
 207 Id. 
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this framework, domains and measures used to evaluate ACOs 
would have “five essential characteristics: consistency, patient-cen-
teredness, team-based care, registry-based information systems, and 
continuous improvement in treatments and delivery.”208 This frame-
work provides a broader, more holistic approach to addressing qual-
ity standards through the ACO model of care. 
A second framework provides a set of “patient-centered” princi-
ples209 that could be used to develop measures that would result in 
“meaningful health outcomes.”210 This framework dictates that a 
quality measure must: 
1. address clinically meaningful, patient-centered 
outcomes; 
2. be developed transparently and be supported by 
robust scientific evidence linking them to improved 
health outcomes in varied settings; 
3. include estimates, expressed in common metrics, 
of anticipated benefits and harms to the population to 
which they are applied; 
4. balance the time and resources required to acquire 
and report data against the anticipated benefits of the 
metric; 
5. be assessed and reported at appropriate levels; they 
should not be applied at the provider level when 
numbers are too small or when interventions to im-
prove them require the action(s) of a system.211 
Measures created through this framework are intended to be ev-
idence-based, ensuring that the measures themselves are effective 
and justified.212 
                                                                                                             
 208 Id. 
 209 Barry G. Saver et al., supra note 155, at 3–6. 
 210 Id. at 4. 
 211 Id. (Box 1. Core Principles for Development and Application of Health 
Care Quality Measures). 
 212 See id. at 3–6. 
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A final framework that could be used to develop a more holistic 
set of quality measures is the CMS Quality Strategy Goals and 
Foundational Principles.213 These goals and principles guide CMS 
activities so as “to optimize health outcomes by improving quality 
and transforming the health care system.”214 While the six strategy 
goals themselves are comprehensive in nature,215 it is the four foun-
dational principles guiding each of these goals that brings the Strat-
egy Goals together to meet a greater mission.216 Such a two-tiered 
structure that includes particular goals driven by underlying princi-
ples is one that would be beneficial in conjunction with the devel-
opment of measures to evaluate ACOs on quality performance. 
IV. PERSPECTIVE #3: ACOS AND ACCESS TO CARE 
The final perspective considers whether ACOs have enhanced 
access to quality care. While critics argue that cost-saving measures 
are creating barriers to needed care,217 a greater concern is whether 
populations most in need are gaining access to the comprehensive 
care of ACOs. One population—Medicaid beneficiaries—could 
benefit most from the ACO model of care. Efforts by CMS to im-
prove Medicaid beneficiary access to ACOs have already begun to 
take effect, though greater action should be taken to incorporate this 
community into the ACO programs. 
                                                                                                             
 213 See generally CTRS. MEDICARE & MEDICAID SERVS., CMS QUALITY 
STRATEGY 2016 1 (2016) [hereinafter CMS QUALITY STRATEGY 2016]. 
 214 CMS QUALITY STRATEGY 2016, supra note 213, at 3. 
 215 See id. at 5 (“The CMS Quality Strategy goals reflect the six priorities set 
out in the National Quality Strategy . . . .”). These six goals include: 1) Make care 
safer by reducing harm caused in the delivery of care; 2) Strengthen person and 
family engagement as partners in their care; 3) Promote effective communication 
and coordination of care; 4) Promote effective prevention and treatment of chronic 
disease; 5) Work with communities to promote best practices of healthy living; 
and 6) Make care affordable. See id. 
 216 These four foundational principles include: 1) Eliminate Racial and Ethnic 
Disparities; 2) Strengthen Infrastructure and Data Systems; 3) Enable Local Inno-
vations; and 4) Foster Learning Organizations. See id. at 5–7. 
 217 See supra notes 197–98. See also Barry G. Saver et al., supra note 155, at 
4 (stating that an Institute of Medicine report in 2015 “highlight[ed] how ‘many 
measures focus on narrow or technical aspects of health care processes, rather 
than on overall health system performance and health outcomes’ and [found] that 
the proliferation of measures ‘. . . create[s] serious problems for public health and 
for health care.’”). 
354 UNIVERSITY OF MIAMI LAW REVIEW [Vol. 71:312 
 
A. ACOs: The “Ivory Towers” of the U.S. Health Care 
Industry? 
It is undeniable that the ACO model of care has had an immedi-
ate impact on the delivery of care—despite certain flaws in the 
model. However, the ACO model of care seems to create a meta-
phorical “ivory tower” of care by affording a luxury—quality care 
at a lower cost—to certain beneficiaries of the American health care 
system—namely Medicare beneficiaries and private payers.218 
When considering the long-term impact of this “ivory tower” on im-
proving the health status of Americans, solely catering to these two 
groups is insufficient. Further, this “ivory tower” effectively blocks 
one major group of beneficiaries from accessing the comprehensive 
care offered by ACOs: Medicaid beneficiaries.219 
Because the statutory formation of the ACO model of care only 
provides for Medicare beneficiaries,220 the ACA left Medicaid ben-
eficiaries relatively precluded from enjoying the comprehensive 
care that ACOs promised to provide.221 However, such a strategy is 
                                                                                                             
 218 Lewis et al., supra note 25, at 1849 (“The coverage of ACOs varie[s] by 
type of payer—21 percent of local areas were served by at least one Medicare 
ACO, 13 percent were served by at least one private payer ACO, and 3 percent 
were served by at least one Medicaid ACO (confined almost entirely to states that 
launched Medicaid ACO projects: Oregon, Minnesota, and New Jersey).”); Ste-
phen M. Shortell et al., Accountable Care Organizations: The National Land-
scape, 40 J. HEALTH POL., POL’Y & L. 647, 649 (2015) (“About half have a con-
tract with a private payer, with 16 percent having a contract with both Medicare 
and a private payer. Thirty-six percent have a contract with Medicare only.”). 
 219 See generally 42 U.S.C. § 1395jjj (statutorily creating the MSSP, which 
caters only to Medicare beneficiaries). 
 220 See generally 42 U.S.C. § 1395jjj. But see KAISER FAM. FOUND., 
EMERGING MEDICAID ACCOUNTABLE CARE ORGANIZATIONS: THE ROLE OF 
MANAGED CARE 1, 2 (2012) (“The ACA also authorized a demonstration project 
for the creation of pediatric ACOs within Medicaid and/or the Children’s Health 
Insurance Program (CHIP). The demonstration project is currently unfunded, but 
states have begun to plan and implement Medicaid ACO initiatives themselves.”) 
 221 John V. Jacobi, Multiple Medicaid Missions: Targeting, Universalism, or 
Both?, 15 YALE J. HEALTH POL’Y, L., & ETHICS 89, 106 (2015) (“The ACA cre-
ated an ACO payment program in Medicare, but did not create a similar program 
in Medicaid.”). 
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short-sighted as “Medicaid disproportionately covers the poor, dis-
abled, and elderly . . . .”222 Similarly, many of these Medicaid ben-
eficiaries are people of color who are regularly denied access to 
quality care—or care in general.223 In effect, because ACOs are stat-
utorily formed to care for Medicare beneficiaries—as opposed to 
Medicare and Medicaid beneficiaries—“[t]he process of creating 
ACOs may reinforce racial or ethnic differences in sites of care,”224 
as well as intensify existing disparities in health for racial and ethnic 
minorities.225 While this likely was not the intention of the architects 
of the ACA, such a statutory loophole disproportionately impacts 
Medicaid beneficiaries who greatly need access to comprehensive 
quality care. It is critical, however, that this statutory loophole be 
addressed to ensure that all those who need health care are able to 
access the benefits of the ACO model of care. 
B. Medicaid and ACOs: An Opportunity for Partnership? 
Several states have taken steps that effectively counteract this 
large loophole in the ACO program, including Colorado, Minnesota, 
Oregon, and Utah.226 The structure of these Medicaid ACOs vary 
                                                                                                             
 222 Id. See also KAISER FAM. FOUND., supra note 225, at 1 (“Medicaid is the 
nation’s public health insurance program for low-income Americans, covering 
close to 60 million children, families, seniors, and people with disabilities.”). 
 223 Craig Evan Pollack & Katrina Armstrong, Accountable Care Organiza-
tions and Health Care Disparities, 305 J. AM. MED. ASS’N 1706, 1706 (2011) 
(“Racial/ethnic disparities in health are well documented in the United States. 
These disparities arise, in part, because of differences in the site of care. Black 
and white patients tend to receive care from different clinicians who work at dif-
ferent hospitals and in different health care systems.”); Ryan E. Anderson et al., 
Quality of Care and Racial Disparities in Medicare Among Potential ACOs, 29 J. 
GEN. INTERNAL MED. 1296, 1296 (2014) (“Because care for racial and ethnic mi-
norities is concentrated among physicians and hospitals with fewer resources, ad-
vanced provider groups ready to participate in ACO programs may disproportion-
ately care for white patients.”). 
 224 Pollack & Armstrong, supra note 223, at 1706. 
 225 See Anderson et al., supra note 223, at 1296. 
 226 Virgil Dickson, Reform Update, States test Medicaid ACOs to cut costs, 
MOD. HEALTHCARE (July 1, 2014), http://www.modernhealthcare.com/article/20
140701/NEWS/307019965. In total, there are currently fifteen states with Medi-
caid ACO models of care; Jacobi, supra note 221, at 106 (“Experimental pro-
grams are growing in several states . . . built on the structure of coordinated care, 
shared clinical decision-making among a large group of Medicaid providers, and 
some form of reward for delivering high-quality care while containing cost.”); 
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from state to state,227 though recent data shows that they all are ef-
fective.228 However, the common characteristic among the current 
Medicaid ACOs is how they are formed; Medicaid ACOs have all 
been legislatively created by states.229 This is a critical point to note 
when considering the formation of Medicaid ACOs on a national 
scale, as the politics of a given state legislature could drastically im-
pact the creation of a Medicaid ACO, and, as a result, compromise 
a Medicaid beneficiary’s ability to access comprehensive care.230 
With this in mind, it would be prudent for the CMS to incentiv-
ize Medicaid ACOs through their current ACO programing rather 
than leave it to each state legislature.231 Such a Medicaid ACO 
                                                                                                             
KAISER FAM. FOUND., supra note 220, at 1, 2–5. See generally Douglas Hervey 
et al., The Rise and Future of Medicaid ACOs, LEAVITT PARTNERS 1, 4 (Sept. 
2015), http://cqrcengage.com/trinityhealth/file/tyuVip0U4gR/LeavittMedicaidA
COSept2015.pdf (Figure 1 mapping the states that have passed legislation for 
Medicaid ACOs); Tricia McGinnis, A Unicorn Realized? Promising Medicaid 
ACO Programs Really Exist, THE COMMONWEALTH FUND (Mar. 11, 2015), 
http://www.commonwealthfund.org/publications/blog/2015/mar/unicorn-real-
ized-medicaid-acos (describing each of the Medicaid ACOs). 
 227 See KAISER FAM. FOUND., supra note 220, at 4; Dickson, supra note 226 
(“The [Medicaid] models differ significantly from state to state.”); Hervey et al., 
supra note 226, at 4 (“[N]o two states’ initiatives are alike. States’ ACO experi-
ments depend on their historical relationship with managed care and their own 
unique challenges associated with their low-income and chronically ill popula-
tions. State ACOs differ in their organizational structures, governance, provider 
eligibility requirements, covered populations, scope of services, required func-
tions, payment models, and quality measures.”). 
 228 See McGinnis, supra note 226. 
 229 See Hervey et al., supra note 226, at 4 (“Despite the historical and antici-
pated growth of Medicaid ACOs, most states’ efforts are still relatively nascent 
as they must undergo lengthy planning processes, accommodate differing stake-
holder concerns, and navigate complex federal and state legislative and regulatory 
requirements in order to implement a Medicaid ACO.”). 
 230 This point is exemplified by the recent trend of states refusing to expand 
their Medicaid program following the landmark decision of National Federation 
of Independent Business v. Sebelius. See Nat’l Fed’n Indep. Bus. v. Sebelius, 132 
S. Ct. 2566, 2607 (2012) (holding that “Congress is not free . . . to penalize States 
that choose not to participate in that new program by taking away their existing 
Medicaid funding [for not expanding coverage].”). However, the reasoning there 
may be indicative of the fact that Medicaid ACOs cannot be imposed on states. 
See id. at 2607–08. 
 231 This strategy of incentivizing participation in the formation of state Medi-
caid ACOs should be done in a manner that does not punish states for not partic-
ipating, as the ACA was thought to do through the expansion of the Medicaid 
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model could simply mirror the current structure of the Medicare 
ACO model in which ACOs are able to earn shared savings by im-
proving the quality of care provided and decreasing the cost of 
care.232 However, these Medicaid ACO programs would need to al-
low for variations among states based on demographics, needs, and 
available funds.233 By incentivizing the formation of Medicaid 
ACOs, the CMS—in partnership with participating states—could 
help close this existing statutory gap in access to care for a vulnera-
ble population that is desperately in need of high quality, compre-
hensive care. 
CONCLUSION 
As with any initiative, only time will tell whether the ACO 
model of care will be able to effectuate the major changes it is de-
signed to bring to the American health system. While this Comment 
offers some criticisms and suggested solutions—based on a review 
of the available literature—it should not be seen as a call to eliminate 
the ACO model of care.234 Rather, this Comment intends to support 
and build on the current conversation concerning the ACO model of 
care, as well as offer strategies for continuously improving the 
model. As the ACO model of care continues to be refined, policy-
makers and health care providers alike will likely be able to better 
meet the desired balance embodied in the “Triple Aim.” However, 
achieving this balance requires that all stakeholders work collabora-
tively to refine a model of care that promises to provide quality care 
at a lower cost for more Americans. In many cases, it already has. 
                                                                                                             
program in each state. See id. Incentivizing, without “blackmailing,” participation 
in Medicaid ACOs would thus keep with the logic of National Federation of In-
dependent Business v. Sebelius. See id. 
 232 See supra Part II. 
 233 See supra note 227. 
 234 See Francis J. Crosson, The Accountable Care Organization: Whatever Its 
Growing Pains, The Concept Is Too Vitally Important To Fail, 30 HEALTH AFF. 
1250, 1250 (2011) (“[N]one [of the criticisms] should serve to prevent the evolu-
tion of this [ACO] model, because the alternative to a fundamental restructuring 
of how health care is delivered and paid for in the United States is likely to be a 
type of indiscriminate cost cutting that will leave the nation with a damaged health 
care system, reduced access to care services, and declining quality of care.”). 
